dailymarijuanaobserverdailymarijuanaobserverhttps://www.dailymarijuanaobserver.com/homeFacts You Need to Know About Cannabis]]>Susie Petersonhttps://www.dailymarijuanaobserver.com/single-post/2020/10/15/Facts-You-Need-to-Know-About-Cannabishttps://www.dailymarijuanaobserver.com/single-post/2020/10/15/Facts-You-Need-to-Know-About-CannabisThu, 15 Oct 2020 14:25:59 +0000
Cannabis has some proven health benefits like relieving arthritic discomfort, reducing the symptoms of Multiple Sclerosis (MS), and so on. However, when you abuse cannabis, it may actually harm your health in numerous ways. Also, federal laws in the U.S. have made it challenging to research the full impact of marijuana on humans. Despite new form factors like edibles becoming more and more popular, even still, there are still minimal findings on edible cannabis. Instead of relying on propaganda out there, the article below will let users know a bit more about cannabis.
Cannabis, Crime, and Delinquency
Most people believe that the abuse of pot is more common among criminals than any other group. However, there is no evidence of the relationship between pot use and illegal behavior. Evidence from Colorado and Washington shows that property criminality and other violent crimes reduced a year after the introduction of cannabis trades in 2014. Another earlier theoretic research in 2012 inspected whether medical marijuana clinics had some relations with law-breaking. The outcome of the investigation detected there were no cross-sectional associations between crime and the rise of medical marijuana clinics.
Pot Smokers and Whether They're Heavy Users
Contrary to what you have heard about cannabis, the fact remains that it may take some time before you feel its effects if you are a first-timer. For example, weed online Canada has several written points when it comes to cannabis and its safety. You don't have to develop cannabis dependency unless you are using it for the wrong purpose. About 50% of people using cannabis take it in lesser than 12 days. Another one-third of pot smokers have consumed marijuana for about ten days in a year. In America, 30 million smokers older than 12 years take pot daily according to research done by the internal survey data.
Cannabis and Cancer
A study done in 2018 and printed in the Thoracic Oncology journal indicated whether cannabis and lung cancer had some relation. The research findings also indicated whether cannabis could ease the pain in cancer patients. Other issues from the investigations showed that up to now, they are yet to find out the relation between heavy marijuana smokers, and the contraindication of tobacco with cannabis use.
Cannabis and Mental Ability
Some recent researches indicate that cannabis use can result in short-term memory if abused. But there is no scientific proof that regular cannabis use can be harmful to your health. Also, taking cannabis will not interfere with your mental ability. This is because very few people will suffer from panics, or paranoia after taking cannabis at first. Like many factors, this too has side effects. But, when it is taken in the right dosage or as per the prescription given by the certified physician, you can prevent the effects and enjoy it fully.
The Bottom Line
Whenever you take cannabis, it will activate your brain's reward system to regions managing the sex and eating response. Cannabis works by activating the neurons in your reward system, thereby bringing a rise in dopamine levels than witnessed in the natural stimuli response. According to weed online Canada, when you combine cannabis and steroids, you will experience physical and mental calm from anxiety, dependency, depression, rapid heartbeats, and so on. As long as you correctly use cannabis, you will not suffer from unwanted side effects. Also, seek counsel from professionals before you embark on using marijuana.
]]>
5 Products Every Vegan Needs When Traveling]]>Susie Petersonhttps://www.dailymarijuanaobserver.com/single-post/5-Products-Every-Vegan-Needs-When-Travelinghttps://www.dailymarijuanaobserver.com/single-post/5-Products-Every-Vegan-Needs-When-TravelingTue, 06 Oct 2020 19:23:02 +0000
This season of life has changed our travel game quite a bit. If you are like us, you can’t wait to get back out there and explore the world! Maybe you will find yourself lost in Los Angeles, or finding comfort at a well-known coffee shop that happens to be on every corner. All we know is, you and your friends are ready to explore! We know that your travel checklist is long and detailed, so we are here to make sure you aren’t forgetting these 5 important products that will make your trips go from blah to fab!
1. CBD Capsules
If you are trying to keep your bags light and leaving your vape kit or pen at home, it may be time to try some Travel-ready CBD capsules. CBDfx is a company that is dedicated to purity, potency, and quality. Their all-natural capsules contain hemp oil that is grown in organic state-of-the-art farms in Kentucky, USA. They pride themselves on using no harmful chemicals or random ingredients. The capsules are made to boost your quality of life and gives you the access to the full power of hemp. Some places you may encounter while traveling will have a strict no-smoking policy. With these capsules, you can still get your CBD ingestion without breaking any hotel rules.
2. Natural Deodorant
Is it just us or does a day of flying leave you feeling not so fresh and quite frankly, odorous? Yeah, we thought so. Not to fear, Kopari is here! Kopari’s coconut deo is a welcomed treat for your underarms while traveling. This non-toxic deo comes in 5 discreet scents or even fragrance-free! Their blend of coconut water and oil along with sage oil, helps to soothe sensitive underarms as well. And because it contains NO aluminum, baking soda, silicone, phthalates, and parabens, you are using only the best of ingredients on your skin. A natural, vegan deodorant that actually works? Sign us up!
3. Face Masks
Don’t let the dry air in the airplane ruin your travel glow. This vegan bubble mask from Sephora will rehydrate and reinvigorate your skin. It contains naturally derived spirulina, that will detoxify and oxygenate your face. It also helps to fight against pollutants all while purifying and brightening your skin. It will take you from 15-hour-flight-face to 15-minute-detoxifying-dame.
4. Sunscreen
Ok, let’s put on our parent pants really quick… Don’t forget to put on your sunscreen! Alright, we got that out. But really, it is 2020. If you STILL aren’t wearing sunscreen, the time is now! Supergoop!’s unseen sunscreen is vegan and cruelty-free (ooo ooo! now it is also reef-safe, in case you are getting in the water!) Its light texture leaves a velvety finish. It is rich in antioxidants and oil-free. This is a great primer for make-up, but of course that SPF 40 works well on its own, so it is a multitasker, just like you. PS: This is a really great SPF for everyday usage. Since 90% of signs of aging comes from the sun, we think it’s about time you add this to your normal regiment.
5. A Good Book
We’re sure you’ve read all the best Veg books by now. So, go ahead and pick your favorite to take with you! Someone may see you reading it and ask about it, allowing you to be able to share your lifestyle with them! If not, it will at least provide that comforting, book-in-your-hand feeling on your long flight (and it may even stop you from buying an insanely overpriced book at the airport).
We can give you all the advice in the world, but the most important thing to do while traveling (and in life actually) is just to be yourself and have fun! Don’t be afraid to try something out of your comfort zone. Traveling will open your mind and help you see things from a different perspective! But you have to be willing to get out there and open your eyes!
]]>
Quintessential Californian Edible Recipes to Make at Home]]>Susie Petersonhttps://www.dailymarijuanaobserver.com/single-post/2020/10/02/Quintessential-Californian-Edible-Recipes-to-Make-at-Homehttps://www.dailymarijuanaobserver.com/single-post/2020/10/02/Quintessential-Californian-Edible-Recipes-to-Make-at-HomeFri, 02 Oct 2020 13:38:54 +0000
California is a top destination for American foodies looking to try high-class, cutting-edge culinary delights. Over 90 eateries across the Golden State have secured at least one prestigious Michelin Star, and seven of the United States’ three-Michelin-Star restaurants are located in the San Francisco Bay Area. It is abundantly clear that Californians know how to make good food.
Fortunately, Californians also know how to grow good weed — and when the food and bud combine, sparks fly. If you are looking to celebrate the Golden State and keep yourself busy during quarantine, here are a few quintessentially Californian edible recipes to recreate at home:
Stoner’s Sourdough
You might recall that month of COVID quarantine when everyone developed a sourdough starter and started baking their own bread from home. Sourdough is such a popular bread because of its relative ease — given that you have been feeding your starter every few days — and its delightful flavor, which is markedly different from the near flavorlessness of typical white or wheat loaves. Sourdough became a staple for early San Franciscans, who found the bread to be especially hardy in mining camps during the Gold Rush and whose starters thrived in the foggy climate.
You can transform any sourdough recipe into a Sour Diesel sourdough by using infused cooking oil, which you can make at home. The process is simple:
Coarsely grind 1 cup of your favorite strain, ideally from a deluxe Berkeley dispensary.
Combine the cannabis and 1 cup olive oil in a double boiler or slow cooker, and heat on low for 4 to 6 hoursStrain the plant solids out of the oil using cheesecloth without squeezing
Once you have an infusion, you can use your cannabis olive oil in your favorite sourdough recipe. Once you have a stoner’s sourdough, you can toast slices of it to use in another Californian recipe.
Avo-Cannabis Toast
Avocado toast is often ridiculed by baby boomers and conservatives as the reason that millennials and progressives can’t afford nice things — but avocado toast made at home is a pretty cost-effective, nutrient-rich snack. Plus, when you make your avo toast DIY-style, you can make it even more opulent by giving it a cannabis twist.
Whether or not you create sourdough bread imbued with marijuana, you can use the infused olive oil from the previous recipe to drizzle on top a slice of bread topped with mashed avocado. The oil plus a squeeze of lemon and a sprinkling of red pepper flakes makes the snack more than rich and savory; it becomes tangy, spicy and fun.
Fish Tacos With Ganja Salsa
When beach culture and Mexican culture combine, you get fish tacos. Fish tacos are a staple of SoCal cuisine; they offer all sorts of delightful flavors and textures while remaining light and refreshing — perfect for a warm summer day at the beach. Even though the beaches are currently closed, you can enjoy your own fish tacos at home — this time with a special ganja sauce.
You can follow your favorite fish taco recipe for the base, but to make the ganja green salsa, mix together the following ingredients in a food processor:
1 grilled green chile, peeled and seeded1 grilled jalapeno, peeled and seeded1 grilled tomatillo, peeled and seeded1/2 small onion, peeled1/2 teaspoon minced garlic1/3 cup minced cilantro1 tablespoon cannabis olive oilLime juice
When you assemble your fish tacos, drizzle some of this salsa on top for more flavor and fun.
Cannabis Cioppino
Cioppino is a fish stew — which might not sound appetizing but is surprisingly one of the most delightfully flavorful foods I have ever tasted. Mixing multiple types of fish and shellfish, Cioppino originated in San Francisco, undoubtedly as a way for Italian-American immigrants to warm up on a chilly summer night.
Cioppino in itself is a culinary adventure, and you might not want to mess with the recipe on your first try. Instead, you might pair your homemade fish stew with a light, lemony strain, like Super Lemon Haze or Jack the Ripper. However, if you are proficient in the kitchen, you can create this cannabis cioppino variant, which puts 1/8 ounce of dried cannabis directly into the broth.
You might never get this chance again — closed restaurants and bars, laws keeping you away from friends and family, and plenty of free time to experiment with cooking and cannabis — so you should make the most of it. If this marijuana menu doesn’t inspire you, you can seek out other easy DIY edibles to keep you entertained and inside.
]]>
How Does Smoking Cannabis Contribute to Your Social Life?]]>Susie Petersonhttps://www.dailymarijuanaobserver.com/single-post/2020/04/08/How-Does-Smoking-Cannabis-Contribute-to-Your-Social-Lifehttps://www.dailymarijuanaobserver.com/single-post/2020/04/08/How-Does-Smoking-Cannabis-Contribute-to-Your-Social-LifeWed, 08 Apr 2020 14:53:53 +0000
(Photo Credit - Circ OD from Pixabay)
Over the past few decades, people’s attitude towards cannabis has changed, and so have the state laws. In 2020, 11 states allow recreational use of cannabis, and its medical use is legalized in 33 states. It’s strictly prohibited for any use in 3 states and decriminalized in 16 - which means that recreational use is illegal, but there are some medical marijuana programs and possession of small amounts doesn’t result in jail time.
The idea of legal medical marijuana brings out polarized opinions. However, it’s the legalization of recreational cannabis that’s the most controversial. States who are in its favor, point out its positive aspects, while states who are against it focus on its drawbacks. In this article, we will discuss both the positive and negative aspects of cannabis use and how it contributes to your social life. Keep on reading to get a better view of this issue!
Quick Recap
According to Reno Nevada dispensary experts, the key to safe and optimal use of cannabis is in moderation. It’s also essential to purchase good quality products from a trusted source. Nevertheless, the opinions differ when it comes to two natural cannabinoid compounds commonly found in plants of the cannabis genus - THC and CBD. Let us remind you real quick what the fuss is all about.
Cannabidiol, a.k.a. CBD is extracted from either hemp or marijuana. Marijuana plants contain higher concentrations of THC alongside it, while in hemp plants the concentration of THC is lower than 0.3%. CBD, unlike THC, is a non-psychoactive compound, which means it doesn’t result in the sense of euphoria. On the other hand, THC is the primary psychoactive compound that gives you the sensation of high. You can consume it by smoking cannabis, and it’s also available in oils, tinctures, capsules, edibles, and more. Both compounds are chemically similar to your body’s cannabinoids, which allows them to interact with your cannabinoid receptors. They are sometimes used to treat similar ailments. CBD can be applied to treating conditions such as pain, seizures, inflammation, depression, anxiety, migraines, psychosis, or some mental disorders. THC is used to help with conditions like insomnia, anxiety, low appetite, pain, or muscle spasticity.
Side-Effects
Despite their chemical similarities, CBD and THC have very different effects. Overall, CBD is tolerated well, even in larger doses, and possible side effects result from its interactions with other medications. It also doesn’t cause euphoric effects. When it comes to THC, it can result in temporary side effects. These include red eyes, slower reaction times, dry mouth, increased heart rate, coordination problems, and sometimes memory loss. These side effects occur due to THC’s psychoactive properties. Nevertheless, it’s worth noting that neither of the compounds is fatal.
The Bigger Picture
Countless studies have corroborated the positive effects of CBD, and the use of cannabis for medical purposes raises fewer and fewer eyebrows as the years go by. It’s clear when you look at the statistics - more than half of the US states have legalized cannabis for medical purposes and other states are expected to follow. However, THC still raises some concerns. Why do people use it so eagerly? In simple words - it’s another way to make them feel good. Psychologists have established that longing for pleasure and comfort, and the need to avoid pain are the most crucial drives that influence human behavior. You probably also know the saying that humans are social creatures. This is why cannabis consumption, along with the physical effects on the body, affects us socially as well.
Effects on your Social Life
Social consequences of cannabis use can be both positive and negative. Opinions on cannabis consumption have changed within society and in many circles, it is widely approved. This approval leads to the feeling of group inclusivity and connectedness. Smoking cannabis can help you create a new network of friends and widen your social circle. You enter a welcoming community, engage in similar activities, and gain knowledge on safe and responsible use. What’s more, positive effects encourage further use in the future. However, problems arise when cannabis consumption gets out of hand.
Cannabis affects people differently. Psychoactive properties of THC can influence your behavior in a way that changes your personality and behavior. Studies show that people who use cannabis excessively can become unmotivated and unproductive. Instead of helping with conditions such as depression, anxiety, and personality disorders, it can make them worse. It can also impair their cognitive skills such as memory, information processing, learning, and attention. Heavy abusers of the substance report that their excessive use and even addiction impact their social life, career status, cognitive abilities, and both physical and mental health in a negative way.
Overall, it’s quite easy to see why some people would like to consume cannabis recreationally. Not only can it positively influence your body, but it can also strengthen your bonds with other members of your community. Nevertheless, this doesn’t apply to excessive use of cannabis. Reason and moderation are your best bet.
]]>
Can You Strengthen Your Immune System With Cannabis?]]>Steven Lachardhttps://www.dailymarijuanaobserver.com/single-post/2020/04/08/Can-You-Strengthen-Your-Immune-System-With-Cannabishttps://www.dailymarijuanaobserver.com/single-post/2020/04/08/Can-You-Strengthen-Your-Immune-System-With-CannabisWed, 08 Apr 2020 14:13:44 +0000
(Photo Credit - Bruno /Germany from Pixabay)
There is no denying that over the years, even if anecdotally, cannabis has proven itself to be one of the most effective ways of treating many diseases, even potentially strengthening the immune system of a person using it.
The legalization of cannabis granted widespread access to a highly medicinal plant that was doing for many what traditional medications and prescriptions could not. With a variety of ailments now accepted by most states' medical marijuana programs, there are an ever-growing number of people qualifying to get a medical marijuana card.
Because of this widespread legalization in the U.S., nowadays, in most of the states across America such as Nevada dispensaries can be found at every corner.
So how exactly does cannabis affect the immune system, and for what diseases can it potentially be used as a treatment? Keep reading if you want to find out.
Cannabis and the Immune System
While there's still little research regarding the effect cannabis has on the human immune system, the one that has been done up to date is quite optimistic.
The main subject of cannabis and immune system research is how cannabis affects people with HIV, which causes AIDS disease. AIDS attacks the person's immune system, which is why it is suggested that the way in which those people react to cannabis will be how everyone's body will respond. If people with weak immune systems can use it, others can too.
A study performed in 2003 by Annals of Internal Medicine, which is one of the academic medical journals, revealed that "Patients receiving cannabinoids had improved immune function compared with those receiving placebo. They also gained about 4 pounds more on average than those patients receiving placebo."
This, as well as two more studies performed, later on, seems to confirm the claim that cannabis has a positive effect on the human immune system. While all this looks promising, further research is still needed.
Cannabis Used as a Treatment
While no study has fully confirmed the effect cannabis has on an immune system, it has been proved that it can be used as an effective treatment of many diseases. This, in a way, also helps people strengthen their immune system and improve their overall health - both mental and physical.
Chronic Pain and Inflammation
Cannabis's ability to relieve pain, as well as to reduce inflammation are two primary reasons as to why the use of marijuana is so popular. The term 'chronic pain' is used to describe the pain that lasts at least 12 weeks. It can affect anyone, any part of the body, and makes everyday activities feel like torture. It can also affect one's psychic.
Since cannabis reduces inflammation, many brands started to make beauty products infused with it, which are meant to help with acne - an inflammatory skin condition.
Cancer
While further research regarding this topic is still needed, several studies have shown that cannabis can be an effective treatment for cancer. Not only does it stop the side effects of chemotherapy like loss of appetite, nausea, and vomiting, but it also can slow down the growth of cancer cells in the lungs, brain, and breast.
What's more, one of the studies showed that cannabis is even able to stop cancer by turning off the Id-1 gene.
Seizures
For years, people were trying to figure out whether cannabis actually helps with epileptic seizures or not. Its usefulness was proven in 2017 when children with epilepsy who were given CBD experienced a reduction in a number of seizures of at least 50%. What's more, 5% of them became utterly seizure-free!
Crohn's Disease
A study performed in Israel has shown that cannabis can be used as an effective treatment of Crohn's disease, which is an inflammatory bowel disorder. The study consisted of 11 patients. Ten of them experienced a reduction of symptoms, while of them have been cured completely.
You might think that it's just one study. However, other studies dealing with this subject have confirmed the results.
PTSD
Cannabis has been proven to be effective when it comes to treating symptoms of PTSD, especially the nightmares and improving the quality of sleep of those who suffer from it. While further research is still needed, it is already being used by many military veterans experiencing PTSD.
Anxiety and Depression
Cannabis increases the production of anandamide, which is a body's natural antidepressant. As it turns out, its elevated level results in a better mood and reduced anxiety. Smoking or taking cannabis also increases the sense of calm.
Final Thoughts
Unfortunately, there isn't yet a specific study that would fully confirm that cannabis has a positive effect on the human immune system. However, research has shown that it can still be used as an effective treatment of many diseases, such as chronic pain, cancer, and epilepsy (seizures).
The legalization of marijuana has not only made access to it easier for people who need it but also opened the door for more research. All we have to do now is wait for the results.
]]>
50 Blue Chip Stocks Worth Less than Half as Much as Tilray]]>Jacob Ellmanhttps://www.dailymarijuanaobserver.com/single-post/2018/09/19/50-Blue-Chip-Stocks-Worth-Less-than-Half-as-Much-as-Tilrayhttps://www.dailymarijuanaobserver.com/single-post/2018/09/19/50-Blue-Chip-Stocks-Worth-Less-than-Half-as-Much-as-TilrayWed, 19 Sep 2018 20:14:53 +0000
On July 19th, 2018, Tilray, Inc. (NASDAQ:TLRY), with an IPO price of just $17 per share, IPOed on the NASDAQ, making it the first company of its kind to do so.
Since then, the company’s value has risen to astronomic proportions as it is now halted at $217.75 per share roughly 44 trading days later. Based on this share price, the company’s market capitalization is estimated to be a whopping $20.28 billion USD.
With a valuation over $20 billion, Tilray is officially more than double the size of some of the most widely known businesses in the world. This list leaves out hundreds of other major public companies that are now minuscule in comparison to Tilray...
CLICK TO READ THE REST OF THE ARTICLE HERE.
]]>
5 of Today's Biggest Marijuana Stock Losers - Monday, September 10th]]>Steven Lachardhttps://www.dailymarijuanaobserver.com/single-post/2018/09/10/5-of-Todays-Biggest-Marijuana-Stock-Losers---Monday-September-10thhttps://www.dailymarijuanaobserver.com/single-post/2018/09/10/5-of-Todays-Biggest-Marijuana-Stock-Losers---Monday-September-10thMon, 10 Sep 2018 20:53:04 +0000
Out of over 200+ marijuana stocks, here are just 5 of the biggest marijuana stock losers in trading on Monday, September 10th including Axim Biotechnologies, Inc. (OTC:AXIM) and more…
Axim Biotechnologies, Inc. (OTC:AXIM)
dropped 6.33%
on higher than average trading volume on the OTC markets, closing the day at $2.07 USD per share. Recently, Axim announced that it has signed an exclusive distribution and license agreement with Revive Therapeutics Ltd.
Body and Mind Inc. (OTC:BMMJ)
Shares of Body and Mind Inc.dropped 14.53%
on lower than average trading volume on the OTC markets, closing the day at $0.32 USD per share. Recently, Body and Mind announced the completion of its Phase II cultivation expansion on its facility located in Las Vegas, Nevada.
FinCanna Capital Corp. (CSE:CALI) (OTC:FNNZF)
dropped 8.15%
today on lower than average trading volume on the OTC markets, closing the day at $0.19013 USD per share. Recently, FinCanna announced the appointment of Mr. Robert Kamm to its Board of Directors.
High Hampton Holdings Corp. (CSE:HC) (OTC:HHPHF)
dropped 7.03%
on lower than average trading volume on the OTC markets, closing the day at $0.3542 USD per share. Recently, High Hampton announced that it has acquired 100% of all outstanding shares of HS Airway Holding.
Pivot Pharmaceuticals Inc. (CSE:PVOT) (OTC:PVOTF)
dropped 9.61%
on higher than average trading volume on the OTC markets, closing the day at $0.30 USD per share. Recently, Pivot announced that Dr. Joseph Borovsky has been appointed as Chairman of the Board of Directors of Pivot Pharmaceuticals.
Tell us which marijuana stocks burned you today! Join the conversation in our Marijuana Stock Forum!
Conclusion
Find more about today's losers by checking out their respective profiles in our global marijuana stock database via the linked tickers above. To stay up to date with important developments in the cannabis industry, be sure to subscribe to one or more of our free email newsletters. Also, connect with The Daily Marijuana Observer on Facebook, Twitter, StockTwits and Instagram!
D/M/O
Disclaimer
Investing in nanocap, microcap, and small cap stocks is highly speculative. The publishers of DailyMarijuanaObserver.com are not registered as Investment Advisors or Broker-Dealers in any jurisdiction whatsoever. The information contained on DailyMarijuanaObserver.com (“this site”) has been prepared solely for informational purposes. Nothing on the site is an offer or solicitation to buy or sell securities. Investors should seek financial advice regarding the appropriateness of investing in any securities mentioned from their financial advisor.
]]>
5 of Today's Biggest Marijuana Stock Gainers - Wednesday, September 5th]]>Steven Lachardhttps://www.dailymarijuanaobserver.com/single-post/2018/09/05/5-of-Todays-Biggest-Marijuana-Stock-Gainers---Wednesday-September-5thhttps://www.dailymarijuanaobserver.com/single-post/2018/09/05/5-of-Todays-Biggest-Marijuana-Stock-Gainers---Wednesday-September-5thWed, 05 Sep 2018 21:08:22 +0000
Out of over 200+ marijuana stocks, here are 5 of the biggest marijuana stock winners in trading on Wednesday, September 5th including Cronos Group Inc. (NASDAQ:CRON) (TSX:CRON) and more...
Aero Grow International, Inc. (OTC:AERO)
rose 10.00% on higher than average trading volume on the OTC markets, closing the day at $2.75 USD per share. Recently, Aero Grow announced results for its first quarter ended June 30, 2018.
Cronos Group Inc. (NASDAQ:CRON) (TSX:CRON)
rose 11.66% on higher than average trading volume on the Nasdaq, closing the day at $12.45 USD per share. Yesterday, Cronos Group announced a landmark partnership to produce cultured cannabinoids.
Helix TCS, Inc. (OTC:HLIX)
Shares of Helix TCS, Inc.rose 11.42%
on higher than average trading volume on the OTC markets, closing the day at $1.20 USD per share. Recently, Helix TCS announced that it has released its 8-K/A disclosing the pro-forma financial statements for the Company’s previously reported merger with Bio-Tech Medical Software, Inc.
Indoor Harvest Corp. (OTC:INQD)
rose 6.56% on lower than average trading volume on the OTC markets, closing the day at $0.065 USD per share. Recently, Indoor Harvest announced its financial results for the three and six months ended June 30, 2018, and to provide a business update.
Namaste Technologies Inc. (TSXV:N) (OTC:NXTTF)
rose 7.68%
on higher than average trading volume on the OTC markets, closing the day at $2.07827 USD per share. Yesterday, Namaste announced that the company has signed a veteran patient services agreement and a medical cannabis supply agreement.
Tell us which marijuana stocks put you in the green today! Join the conversation in our Marijuana Stock Forum!
Conclusion
Find more about today's gainers by checking out their respective profiles in our global marijuana stock database via the linked tickers above. To stay up to date with important developments in the cannabis industry, be sure to subscribe to one or more of our free email newsletters. Also, connect with The Daily Marijuana Observer on Facebook, Twitter, StockTwits and
D/M/O
Disclaimer
Investing in nanocap, microcap, and small cap stocks is highly speculative. The publishers of DailyMarijuanaObserver.com are not registered as Investment Advisors or Broker-Dealers in any jurisdiction whatsoever. The information contained on DailyMarijuanaObserver.com (“this site”) has been prepared solely for informational purposes. Nothing on the site is an offer or solicitation to buy or sell securities. Investors should seek financial advice regarding the appropriateness of investing in any securities mentioned from their financial advisor.
]]>
5 of Today's Biggest Marijuana Stock Losers - Wednesday, September 5th]]>Steven Lachardhttps://www.dailymarijuanaobserver.com/single-post/2018/09/05/5-of-Todays-Biggest-Marijuana-Stock-Losers---Wednesday-September-5thhttps://www.dailymarijuanaobserver.com/single-post/2018/09/05/5-of-Todays-Biggest-Marijuana-Stock-Losers---Wednesday-September-5thWed, 05 Sep 2018 20:43:11 +0000
Out of over 200+ marijuana stocks, here are just 5 of the biggest marijuana stock losers in trading on Wednesday, September 5th including CannTrust Holdings Inc. (TSX:TRST) (OTC:CNTTF) and more…
CannTrust Holdings Inc. (TSX:TRST) (OTC:CNTTF)
dropped 6.25%
on higher than average trading volume on the OTC markets, closing the day at $7.68764 USD per share. Today, CannTrust announced that it is pleased to collaborate with Hamilton Health Sciences and McMaster University.
Emerald Health Therapeutics Inc. (TSXV:EMH) (OTC:EMHTF)
Shares of Emerald Health Therapeutics Inc.dropped 7.43%
on higher than average trading volume on the OTC markets, closing the day at $3.24 USD per share. Recently, Emerald Health reported 2nd Quarter 2018 financial results and provided a corporate update.
KushCo Holdings Inc. (OTC:KSHB)
dropped 8.15%
today on higher than average trading volume on the OTC markets, closing the day at $5.41 USD per share. Yesterday, Kush Bottles announced that it had officially changed its name to KushCo Holdings, Inc.
MedMen Enterprises Inc. (CSE:MMEN) (OTC:MMNFF)
dropped 14.29%
on higher than average trading volume on the OTC markets, closing the day at $4.26 USD per share. Recently, MedMen announced the appointment of Benjamin Rose as non-executive chairman of its board of directors effective immediately.
MYM Nutraceuticals Inc. (CSE:MYM) (OTC:MYMMF)
dropped 5.27%
on higher than average trading volume on the OTC markets, closing the day at $0.91994 USD per share. Today, MYM provided an update on its, currently under construction, 1.5 million sq. ft. cannabis greenhouse production facility, located in Weedon, Quebec.
Tell us which marijuana stocks burned you today! Join the conversation in our Marijuana Stock Forum!
Conclusion
Find more about today's losers by checking out their respective profiles in our global marijuana stock database via the linked tickers above. To stay up to date with important developments in the cannabis industry, be sure to subscribe to one or more of our free email newsletters. Also, connect with The Daily Marijuana Observer on Facebook, Twitter, StockTwits and Instagram!
D/M/O
Disclaimer
Investing in nanocap, microcap, and small cap stocks is highly speculative. The publishers of DailyMarijuanaObserver.com are not registered as Investment Advisors or Broker-Dealers in any jurisdiction whatsoever. The information contained on DailyMarijuanaObserver.com (“this site”) has been prepared solely for informational purposes. Nothing on the site is an offer or solicitation to buy or sell securities. Investors should seek financial advice regarding the appropriateness of investing in any securities mentioned from their financial advisor.
]]>
5 of Today's Biggest Marijuana Stock Gainers - Tuesday, September 4th]]>Steven Lachardhttps://www.dailymarijuanaobserver.com/single-post/2018/09/04/5-of-Todays-Biggest-Marijuana-Stock-Gainers---Tuesday-September-4thhttps://www.dailymarijuanaobserver.com/single-post/2018/09/04/5-of-Todays-Biggest-Marijuana-Stock-Gainers---Tuesday-September-4thTue, 04 Sep 2018 23:48:45 +0000
Out of over 200+ marijuana stocks, here are 5 of the biggest marijuana stock winners in trading on Tuesday, September 4th including Canopy Growth Corporation (TSX:WEED) (NYSE:CGC) and more...
Canopy Growth Corporation (TSX:WEED) (NYSE:CGC)
rose 14.61% on higher than average trading volume on the NYSE, closing the day at $52.40 USD per share. Recently, Hiku Brands Company Ltd. has announced that shareholders have passed a resolution to approve the corporation’s previously announced plan of arrangement with Canopy Growth Corporation.
Cronos Group Inc. (NASDAQ:CRON) (TSX:CRON)
rose 12.85% on higher than average trading volume on the Nasdaq, closing the day at $11.15 USD per share. Today, Cronos Group announced a landmark partnership to produce cultured cannabinoids.
KushCo Holdings Inc. (OTC:KSHB)
Shares of KushCo Holdings Inc.rose 10.51%
on lower than average trading volume on the OTC markets, closing the day at $5.89 USD per share. Today, Kush Bottles announced that it had officially changed its name to KushCo Holdings, Inc.
MedMen Enterprises Inc. (CSE:MMEN) (OTC:MMNFF)
rose 19.19% on higher than average trading volume on the OTC markets, closing the day at $4.97 USD per share. Recently, MedMen announced the appointment of Benjamin Rose as non-executive chairman of its board of directors effective immediately.
Namaste Technologies Inc. (TSXV:N) (OTC:NXTTF)
rose 20.62%
on higher than average trading volume on the OTC markets, closing the day at $1.93 USD per share. Today, Namaste announced that the company has signed a veteran patient services agreement and a medical cannabis supply agreement.
Tell us which marijuana stocks put you in the green today! Join the conversation in our Marijuana Stock Forum!
Conclusion
Find more about today's gainers by checking out their respective profiles in our global marijuana stock database via the linked tickers above. To stay up to date with important developments in the cannabis industry, be sure to subscribe to one or more of our free email newsletters. Also, connect with The Daily Marijuana Observer on Facebook, Twitter, StockTwits and
D/M/O
Disclaimer
Investing in nanocap, microcap, and small cap stocks is highly speculative. The publishers of DailyMarijuanaObserver.com are not registered as Investment Advisors or Broker-Dealers in any jurisdiction whatsoever. The information contained on DailyMarijuanaObserver.com (“this site”) has been prepared solely for informational purposes. Nothing on the site is an offer or solicitation to buy or sell securities. Investors should seek financial advice regarding the appropriateness of investing in any securities mentioned from their financial advisor.
]]>
5 of Today's Biggest Marijuana Stock Losers - Tuesday, September 4th]]>Steven Lachardhttps://www.dailymarijuanaobserver.com/single-post/2018/09/04/5-of-Todays-Biggest-Marijuana-Stock-Losers---Tuesday-September-4thhttps://www.dailymarijuanaobserver.com/single-post/2018/09/04/5-of-Todays-Biggest-Marijuana-Stock-Losers---Tuesday-September-4thTue, 04 Sep 2018 22:28:09 +0000
Out of over 200+ marijuana stocks, here are just 5 of the biggest marijuana stock losers in trading on Tuesday, September 4th including India Globalization Capital, Inc. (NYSE:IGC) and more…
Affinor Growers Inc. (CSE:AFI) (OTC:RSSFF)
dropped 8.90%
on higher than average trading volume on the OTC markets, closing the day at $0.0777 USD per share. Recently, Affinor Growers announced the Government of Aruba approved a vertical farming project using Affinor Growers’ technology.
Freedom Leaf, Inc. (OTC:FRLF)
Shares of Freedom Leaf, Inc.dropped 6.93%
on lower than average trading volume on the OTC markets, closing the day at $0.1585 USD per share. Recently, Freedom Leaf announced that it’s wholly owned subsidiary, Tierra Science Global, launched a national tour and global webinar series for its affiliate platform.
India Globalization Capital, Inc. (NYSE:IGC)
dropped 20.60%
today on higher than average trading volume on the OTC markets, closing the day at $1.31 USD per share. Recently, India Globalization Capital announced that it has designated California as a priority market for Hyalolex.
United Cannabis Corp. (OTC:CNAB)
dropped 10.17%
on lower than average trading volume on the OTC markets, closing the day at $0.53 USD per share. Recently, United Cannabis announced that it has initiated clinical trials on its Prana Bio Nutrient Medicinals P1 Capsules for the treatment of chronic pain at Jamaica's University of the West Indies.
Veritas Pharma Inc (CSE:VRT) (OTC:VRTHF)
dropped 6.87%
on higher than average trading volume on the OTC markets, closing the day at $0.1695 USD per share. Recently, Veritas Pharma announced that the company has completed the share purchase agreement to acquire fifty percent of the issued and outstanding shares of 3 Carbon Extractions Inc.
Tell us which marijuana stocks burned you today! Join the conversation in our Marijuana Stock Forum!
Conclusion
Find more about today's losers by checking out their respective profiles in our global marijuana stock database via the linked tickers above. To stay up to date with important developments in the cannabis industry, be sure to subscribe to one or more of our free email newsletters. Also, connect with The Daily Marijuana Observer on Facebook, Twitter, StockTwits and Instagram!
D/M/O
Disclaimer
Investing in nanocap, microcap, and small cap stocks is highly speculative. The publishers of DailyMarijuanaObserver.com are not registered as Investment Advisors or Broker-Dealers in any jurisdiction whatsoever. The information contained on DailyMarijuanaObserver.com (“this site”) has been prepared solely for informational purposes. Nothing on the site is an offer or solicitation to buy or sell securities. Investors should seek financial advice regarding the appropriateness of investing in any securities mentioned from their financial advisor.
]]>
Aphria Partners with Danish Flower Producer]]>D.M.O. Newswirehttps://www.dailymarijuanaobserver.com/single-post/2018/09/04/APH-Aphria-Partners-with-Danish-Flower-Producerhttps://www.dailymarijuanaobserver.com/single-post/2018/09/04/APH-Aphria-Partners-with-Danish-Flower-ProducerTue, 04 Sep 2018 15:39:59 +0000
Leamington, ON — September 4, 2018 — /D.M.O. Newswire/ — Aphria Inc. (“Aphria” or the “Company”) (TSX:APH) (OTC:APHQF) today announced that it has entered into a strategic partnership (the “Partnership”) with Schroll Medical (‘Schroll” or the “Danish Company”), a subsidiary of prominent European flower producer, Schroll Flowers. The Partnership will pursue the cultivation and worldwide distribution of organic, EU GMP-certified medical cannabis, and will be managed by the Company’s wholly-owned subsidiary Aphria Deutschland GmbH (“Aphria Germany”). The deal accelerates Aphria’s global expansion, in collaboration with an established and world-class partner, with first product expected to be available by early 2019.
“Aphria continues to execute on its strategy for international expansion, and we are pleased to have joined forces with a highly-regarded, experienced grower known around the world for its quality,” said Vic Neufeld, Chief Executive Officer at Aphria. “Our co-founders come from the world of commercial agriculture, including commercial flower production, so we speak the same language as Schroll and we bring to this Partnership the best-in-class know-how to produce high-quality, clean and pure medical cannabis for the worldwide market. Partnerships such as this continue to build upon Aphria’s foundation for long-term sustained growth in every market in which we operate.”
In exchange for a 15% interest in the Partnership, Aphria is providing €100,000 to the Partnership, its leadership in cannabis greenhouse cultivation and experience in processing and worldwide distribution. This will include, but is not limited to, consulting on GMP certification, cannabis genetics and strains, and proprietary growing IP. Aphria will also handle the worldwide distribution of medical cannabis produced by the Partnership, which is anticipated to be made available to markets in Germany, Luxembourg, Switzerland and other developing medical cannabis markets. As part of the deal, Aphria maintains a path to increase its ownership interest to 50% and a path to realize full liquidity, each under certain conditions.
“This marks another important step in advancing the availability of high-quality medical cannabis for across Europe and around the world,” said Hendrik Knopp, Managing Director of Aphria Germany. “We are pleased to take a leadership role and to bring our considerable experience in cultivation, along with our expanding distribution network, to ensure a successful and beneficial Partnership.”
Schroll will hold an 85% interest in the Partnership and will be responsible for the EU GMP-certified cultivation of certified organic medical cannabis. The Danish Company has already received its license for the cultivation of medical cannabis from the Danish Medicines Agency, and currently owns property where the production has already started in a retrofit greenhouse. Construction on Phase 1 is underway and involves a modification of an existing facility of 9,000 square meters as well as building of a new processing facility of 1,000 square meters.
Said Carsten Schroll, founder of Schroll Flowers: “This initiative with Aphria, one of the world’s leading cannabis companies, results in a number of important synergies for Schroll. We are pleased to share a background in cultivation, look forward to applying the expertise and knowledge from Aphria to produce the highest standard of organic medical cannabis to reach patients in need around the world.”
We Have A Good Thing Growing
About Aphria
Aphria is a leading global cannabis company driven by an unrelenting commitment to our people, product quality and innovation. Headquartered in Leamington, Ontario – the greenhouse capital of Canada – Aphria has been setting the standard for the low-cost production of safe, clean and pure pharmaceutical-grade cannabis at scale, grown in the most natural conditions possible. Focusing on untapped opportunities and backed by the latest technologies, Aphria is committed to bringing breakthrough innovation to the global cannabis market. The Company’s portfolio of brands is grounded in expertly-researched consumer insights designed to meet the needs of every consumer segment. Rooted in our founders’ multi-generational expertise in commercial agriculture, Aphria drives sustainable long-term shareholder value through a diversified approach to innovation, strategic partnerships and global expansion, with a presence in more than 10 countries across 5 continents.
For more information, visit: aphria.ca
CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS:Certain information in this news release constitutes forward-looking statements under applicable securities laws. Any statements that are contained in this news release that are not statements of historical fact may be deemed to be forward-looking statements. Forward looking statements are often identified by terms such as “may”, “should”, “anticipate”, “expect”, “potential”, “believe”, “intend” or the negative of these terms and similar expressions. Forward-looking statements in this news release include, but are not limited to, statements with respect to internal expectations, estimated margins, expectations with respect to actual production volumes, expectations for future growing capacity and costs, the completion of any capital project or expansions, and expectations with respect to future production costs. Forward-looking statements necessarily involve known and unknown risks, including, without limitation, risks associated with general economic conditions; adverse industry events; marketing costs; loss of markets; future legislative and regulatory developments involving medical marijuana; inability to access sufficient capital from internal and external sources, and/or inability to access sufficient capital on favourable terms; the medical marijuana industry in Canada generally, income tax and regulatory matters; the ability of Aphria to implement its business strategies; competition; crop failure; currency and interest rate fluctuations and other risks.
Readers are cautioned that the foregoing list is not exhaustive. Readers are further cautioned not to place undue reliance on forward-looking statements as there can be no assurance that the plans, intentions or expectations upon which they are placed will occur. Such information, although considered reasonable by management at the time of preparation, may prove to be incorrect and actual results may differ materially from those anticipated.
Forward-looking statements contained in this news release are expressly qualified by this cautionary statement.
]]>
Namaste Announces Medical Cannabis Supply Agreement]]>D.M.O. Newswirehttps://www.dailymarijuanaobserver.com/single-post/2018/09/04/N-Namaste-Announces-Medical-Cannabis-Supply-Agreementhttps://www.dailymarijuanaobserver.com/single-post/2018/09/04/N-Namaste-Announces-Medical-Cannabis-Supply-AgreementTue, 04 Sep 2018 15:17:29 +0000
Vancouver, B.C. — September 4, 2018 — /D.M.O. Newswire/ — Namaste Technologies Inc. (“Namaste” or the “Company”) (TSXV:N) (FRANKFURT:M5BQ) (OTC:NXTTF) is pleased to announce that the Company has signed a veteran patient services agreement (“Patient Services Agreement”) and a medical cannabis supply agreement (the “Supply Agreement”) with Breton CannaPharms Ltd. (“Breton CannaPharms” or “Bretoncannabis.com”). Breton CannaPharms has a very strong presence in veteran communities across Canada and the entire management team has extensive experience in holistically servicing veterans and educating communities on the positive and misunderstood effects of medical cannabis to treat veterans suffering from both chronic pain and post-traumatic stress disorder (“PTSD”).
Namaste is focused on supporting various initiatives surrounding veteran communities and on providing free access to its online patient platform, NamasteMD Inc. (“NamasteMD.com”).
Under the terms of the Patient Services Agreement, Breton Farms will work exclusively with NamasteMD to target patient acquisition within veteran groups across the country. Namaste is proud to partner with Breton Cannabis to focus on acquiring veteran patients and servicing their needs through its Access to Cannabis for Medical Purposes Regulations (“ACMRP”) Licensed Producer partners. NamasteMDprovides convenient access to nurse practitioners for medical consultations through online video and is available on the Apple Store, Google Play devices and online at NamasteMD.com.
Further to the Patient Services Agreement, Namaste has also signed a Supply Agreement with Breton Cannabis, whereby the Company will purchase bulk cannabis products from Breton CannaPharms to offer on its online platform through the Company’s wholly owned-subsidiary and ACMPR Licensed Producer, Cannmart Inc. (“Cannmart”). Namaste will focus on offering Breton CannaPharms high potency strains that are specifically cultivated to meet the demand of its veteran patients.
Veteran Affairs Canada provides veterans with reimbursements on cannabis for medical purposes, for up to 3 grams of cannabis per day, under the terms of their reimbursement policy POC-10. Furthermore, veterans are entitled to coverage of up to $300 every three years for a medical vaporizer prescribed by their doctor for an awarded pensioned condition. Medical vaporizers are sold and distributed by Namaste. Under the terms of the Patient Services Agreement, Breton CannaPharms management team, who are well versed with Veteran’s entitlements and direct-billing coverage, will assist Namaste in the management of its veteran patients to ensuring the highest level of care possible.
Both agreements exemplify Namaste’s strategy in leveraging its technology assets through partnerships with organizations like Breton CannaPharms and in providing added-value for medical patients across Canada. Namaste strongly believes that the veteran community remains highly under-served in today’s market. The partnership with Breton CannaPharms will not only serve to drive highly valuable veteran patient growth but also provides education and awareness regarding the impact of medical cannabis for veterans who suffer from chronic pain and severe trauma.
Through its partnership with Breton CannaPharms, Namaste will focus on building a section on Cannmart to offer specialty products specifically for veteran patients. Namaste will leverage its AI platform through its wholly owned subsidiary, Findify AB (“Findify”) to study the effects of various medical cannabis strains and how they impact veterans suffering from pain and post-traumatic stress disorder (“PTSD”). The goal of the AI integration with Findify is to help provide better strain recommendations based on a patient’s specific condition and improve the user experience. By adding value for Namaste’s patients through technological innovation, Namaste will set the highest benchmark for patient care and solidify its position as Canada’s leading cannabis e-commerce retailer.
Namaste is also pleased to provide further information for share purchases to-date, subject to the Company’s Normal Course Issuer Bid (“NCIB”), through the facilities of the Toronto Venture Exchange (“TSXV”) below;
July 2018 – 1,111,700 shares at an average price of $1.357 CAD
August 2018 – 1,056,000 shares at an average price of $1.349 CAD
Total – 2,167,700 shares at an average price of $1.354 CAD
Management Commentary
Fabian Henry, Founder of Breton CannaPharms comments: “After half a decade assisting and educating Licensed Producers in the cannabis industry, it’s a true pleasure to finally partner with a professional group like Namaste Technologies.
Namaste’s leadership with its craft approach, patient acquisition strategy and their NamasteMD platform made easy, are extremely welcomed to the veteran community. This strategic partnership will allow veterans nationally to access a wide variety of medical craft cannabis and vaporizers on one platform, while adding more options on how veterans can manage their own healthcare.
Their success in e-commerce both in Canada and internationally have shown what Namaste Technologie is exceptionally capable of world-wide. On behalf of the Breton CannaPharms team, we are very pleased to join the Namaste family and look forward to a long-lasting working relationship with veterans for healing as our end state. ”
Fabian Henry founded Marijuana for Trauma (“MFT”) in 2013. MFT is a chain of medical cannabis clinics across Canada with over 8,000 registers patients. After completing an RTO with Licensed Producer Abba Medix in 2016, Fabian donated 100% of his ownership to a charity for veterans called the GAFF (Global Alliance Foundation Fund).
In summer 2017, Mr. Henry moved towards becoming a Licensed Producer by acquiring a 75,000 sq ft building with 14 acres in Cape Breton, Nova Scotia. The Breton CannaPharms team is poised for success and anticipates producing 12,500 kg of high-quality cannabis per year.
Mr Henry was instrumental in building value in selling product and assisting Licensed Producers with the processes associated with a comprehensive treatment plan for veterans by gaining approved coverage under Veterans Affairs Canada.
Sean Dollinger, President and CEO of Namaste comments: “We’re very proud to have partnered with Breton CannaPharms on this exciting project. We believe strongly in supporting our veterans and that our technology will help improve veteran access to medical cannabis for pain and trauma treatment. Breton CannaPharms management team are highly respected in the veteran communities across Canada and will bring significant value to Namaste in helping to acquire and service veteran patients within our platform.
We’re also pleased to have signed a supply agreement with Breton CannaPharms at the same time, which will ensure supply of high potency strains of cannabis that are grown specifically for veterans, to be offered as a stand-alone category within Cannmart’s online marketplace.
We’re focused on enhancing the lives of veterans not only in Canada but globally, and in using our technology for the greater good.”
About Breton Cannabis Group
Breton Cannabis Group (“BCG”) is a fully integrated late stage ACMPR Applicant Focused on medical and adult use cannabis in Canada.
Led by a team of experienced Industry experts who have built and run multiple successful medical marijuana clinics across Canada, BCG will use that valuable data to properly select and secure the appropriate phenotypes for our patient populations specific chronic injury and illnesses.
We are growing craft cannabis for a targeted medical group using the best of breed genetics, data analytics, and growing techniques.
Using-cutting edge tech to track and manage supply for two reasons: 1. Eliminate human error from shipping direct to patient and 2. Manage supply and back up supply to fit medical group’s needs, especially mental health.
About Namaste Technologies Inc.
Namaste Technologies is Your Everything Cannabis Store™. Namaste operates the largest global cannabis e-commerce platform with over 30 websites in 20+ countries under various brands. Namaste’s product offering through its subsidiaries includes vaporizers, glassware, accessories, CBD products, and the company will soon be selling medical cannabis in the Canadian market, subject to approval by Health Canada.
Namaste has developed and acquired innovative technology platforms including NamasteMD.com, Canada’s first Health Canada compliant telemedicine application, and in May 2018 the Company acquired a leading e-commerce AI and Machine Learning Company, Findify AB. Findify uses artificial intelligence algorithms to optimize and personalize a consumer’s on-site buying experience. Namaste is focused on leveraging its cutting-edge technology to enhance the user experience throughout its platforms. Namaste will continue to develop and acquire innovative technologies which will provide value to the Company and to its shareholders as well as to the broader cannabis market.
On behalf of the Board of Directors
“Sean Dollinger”
Chief Executive Officer
Direct: +1 604-355-6100
Email: info@namastetechnologies.com
Further information on the Company and its products can be accessed through the links below:
NamasteTechnologies.com
NamasteMD.com
NamasteVapes.ca
Everyonedoesit.ca
FORWARD-LOOKING INFORMATIONThis press release contains forward-looking information based on current expectations. These statements should not be read as guarantees of future performance or results. Such statements involve known and unkno wn risks, uncertainties and other factors that may cause actual results, performance or achievements to be materially different from those implied by such statements. Although such statements are based on management’s reasonable assumptions, Namaste assumes no responsibility to update or revise forward-looking information to reflect new events or circumstances unless required by law. Although the Company believes that the expectations and assumptions on which the forward-looking statements are based are reasonable, undue reliance should not be placed on the forward-looking statements because the Company can give no assurance that they will prove to be correct. Since forward-looking statements address future events and conditions, by their very nature they involve inherent risks and uncertainties. These statements speak only as of the date of this press release. Actual results could differ materially from those currently anticipated due to a number of factors and risks including various risk factors discussed in the Company’s disclosure documents which can be found under the Company’s profile on www.sedar.com. This press release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. The TSXV has neither reviewed nor approved the contents of this press release.
]]>
Aurora Cannabis Closes $200 Million Debt Facility with BMO]]>D.M.O. Newswirehttps://www.dailymarijuanaobserver.com/single-post/2018/09/04/Aurora-Cannabis-Closes-200-Million-Debt-Facility-with-BMOhttps://www.dailymarijuanaobserver.com/single-post/2018/09/04/Aurora-Cannabis-Closes-200-Million-Debt-Facility-with-BMOTue, 04 Sep 2018 14:50:40 +0000
Edmonton, AB — September 4, 2018 — /D.M.O. Newswire/ — Aurora Cannabis Inc. (“Aurora” or the “Company”) (TSX:ACB) (OTC:ACBFF) (FRA:21P) today announced that it has closed its previously announced debt facility with the Bank of Montreal (“BMO”). The facility consists of a $150 million term loan and a $50 million revolving credit facility (together, the “Loans”), both of which mature in 2021. Included in the facility is an option to upsize the facility to $250 million total following the implementation of Bill C-45 on October 17, 2018, subject to agreement by BMO and satisfaction of certain legal and business conditions.
The debt facility is primarily secured by Aurora’s production facilities, including Aurora Sky, Aurora Mountain, and Aurora Vie. Strategically located at Edmonton International Airport, Aurora Sky is the world’s most technologically advanced cannabis facility, projected to produce in excess of 100,000 kg per year of high-quality, low-cost per gram, cannabis upon completion.'
“We are incredibly proud to have successfully closed this historic debt facility supported by a premier Canadian bank, BMO, who understands our needs and potential. This is both a reflection of the rapidly maturing nature of the broader cannabis industry and strong validation of the economic potential of Aurora’s best-in-class, technologically advanced production facilities,” said Terry Booth, CEO of Aurora. “With BMO and the syndicate lenders, Aurora gains significant runway to expansion opportunities that will positively contribute to our long-term margin profile and provide accelerated entry into multiple international markets. This additional capital positions us well to continue building the pre-eminent global cannabis company with a focus on vertically integrated, geographically and horizontally diversified assets.”
Glen Ibbott, CFO of Aurora, added, “The closing conditions of this debt facility included stringent due diligence of Aurora’s current production facilities as well as a thorough review of Aurora’s projected revenue growth across all of our divisions. With our extremely strong balance sheet, Aurora is well positioned to execute on our business strategy, including accelerated development and launch of new products, continued rapid expansion of our domestic and international operations, and entry into new global markets.”
Pursuant to the agreed upon conditions of the Loans, Aurora may, at its discretion, repay the balance of the Loans without penalty, at any time. The pricing of the Loans is a set margin over the BMO CAD Prime Rate or a Bankers’ Acceptance of appropriate term. Based on the current BMO CAD Prime Rate, the interest payable is expected to be in the mid to high 4% per annum range over the term of the Loans. Additional details on this new sector benchmark debt facility can be found in the Company’s documents that have been filed on www.sedar.com.
About Aurora
Headquartered in Edmonton, Alberta, Canada with funded capacity in excess of 570,000 kg per year and sales and operations in 14 countries across five continents, Aurora is one of the world’s largest and leading cannabis companies. Aurora is vertically integrated and horizontally diversified across every key segment of the value chain, from facility engineering and design to cannabis breeding and genetics research, cannabis and hemp production, derivatives, high value-add product development, home cultivation, wholesale and retail distribution.
Highly differentiated from its peers, Aurora has established a uniquely advanced, consistent and efficient production strategy, based on purpose-built facilities that integrate leading-edge technologies across all processes, defined by extensive automation and customization, resulting in the massive scale production of high quality product at ultra-low costs. Intended to be replicable and scalable globally, these production facilities are designed to produce cannabis of significant scale, with high quality, industry-leading yields, and ultra-low per gram production costs. Each of Aurora’s facilities is built to meet European Union (EU) GMP standards, and its first production facility, the recently acquired MedReleaf Markham facility, and its wholly owned European medical cannabis distributor Aurora Europe GmbH, have achieved this level of certification.
In addition to the Company’s rapid organic growth and strong execution on strategic M&A, which to date includes 10 companies acquired – MedReleaf, CanvasRx, Peloton Pharmaceutical, Pedanios, H2 Biopharma, Urban Cultivator, BC Northern Lights, Larssen Greenhouses, CanniMed Therapeutics, and Anandia – Aurora is distinguished by its reputation as a partner of choice and employer of choice in the global cannabis sector, having invested in and established strategic partnerships with a range of leading innovators, including: The Green Organic Dutchman Holdings Ltd. (TSX: TGOD), Radient Technologies Inc. (TSXV: RTI), Hempco Food and Fiber Inc. (TSXV: HEMP), Cann Group Ltd. (ASX: CAN), Micron Waste Technologies Inc. (CSE: MWM), Choom Holdings Inc. (CSE: CHOO), Namaste Technologies Inc. (TSXV: N), Evio Beauty Group (private), Wagner Dimas (private), CTT Pharmaceuticals (OTCC: CTTH), Capcium Inc. (private), and Alcanna Inc. (TSX: CLIQ).
Aurora’s Common Shares trade on the TSX under the symbol “ACB”, and are a constituent of the S&P/TSX Composite Index.
For more information about Aurora, please visit our investor website, investor.auroramj.com, Twitter, Facebook or Instagram.
Terry Booth, CEO Aurora Cannabis Inc.
Forward Looking Statements
This news release includes statements containing certain “forward-looking information” within the meaning of applicable securities law (“forward-looking statements”). Forward-looking statements are frequently characterized by words such as “plan”, “continue”, “expect”, “project”, “intend”, “believe”, “anticipate”, “estimate”, “may”, “will”, “potential”, “proposed” and other similar words, or statements that certain events or conditions “may” or “will” occur. These statements are only predictions. Various assumptions were used in drawing the conclusions or making the projections contained in the forward-looking statements throughout this news release. Forward-looking statements are based on the opinions and estimates of management at the date the statements are made, and are subject to a variety of risks and uncertainties and other factors that could cause actual events or results to differ materially from those projected in the forward-looking statements. The Company is under no obligation, and expressly disclaims any intention or obligation, to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as expressly required by applicable law.
Neither TSX nor its Regulation Services Provider (as that term is defined in the policies of Toronto Stock Exchange) accepts responsibility for the adequacy or accuracy of this release.
]]>
5 of Today's Biggest Marijuana Stock Gainers - Thursday, August 30th]]>Steven Lachardhttps://www.dailymarijuanaobserver.com/single-post/2018/08/30/5-of-Todays-Biggest-Marijuana-Stock-Gainers---Thursday-August-30thhttps://www.dailymarijuanaobserver.com/single-post/2018/08/30/5-of-Todays-Biggest-Marijuana-Stock-Gainers---Thursday-August-30thThu, 30 Aug 2018 20:59:12 +0000
Out of over 200+ marijuana stocks, here are 5 of the biggest marijuana stock winners in trading on Thursday, August 30th including CV Sciences, Inc. (OTC:CVSI) and more...
CannTrust Holdings Inc. (TSX:TRST) (OTC:CNTTF)
rose 6.27% on higher than average trading volume on the OTC markets, closing the day at $7.97 USD per share. Recently, CannTrust announced thatit will continue to put medical cannabis patients’ needs first and will absorb the Federal Government’s Excise Tax on medical cannabis.
CV Sciences, Inc. (OTC:CVSI)
rose 27.10% on higher than average trading volume on the OTC markets, closing the day at $4.08 USD per share. Today, CV Sciences provided a corporate update to shareholders.
Indoor Harvest Corp. (OTC:INQD)
Shares of Indoor Harvest Corp.rose 12.50%
on lower than average trading volume on the OTC markets, closing the day at $0.0675 USD per share. Recently, Indoor Harvest announced its financial results for the three and six months ended June 30, 2018.
INSYS Therapeutics Inc. (NASDAQ:INSY)
rose 34.05% on higher than average trading volume on the Nasdaq, closing the day at $10.67 USD per share. Today, INSYS announced that the U.S. Food and Drug Administration has granted Fast Track designation to the company’s epinephrine nasal spray.
Marapharm Ventures Inc. (CSE:MDM) (OTC:MRPHF)
rose 6.93%
on lower than average trading volume on the OTC markets, closing the day at $0.179 USD per share. Recently, Marapharm announced the fully funded operating agreement with Full Spectrum Medicinal Inc.
Tell us which marijuana stocks put you in the green today! Join the conversation in our Marijuana Stock Forum!
Conclusion
Find more about today's gainers by checking out their respective profiles in our global marijuana stock database via the linked tickers above. To stay up to date with important developments in the cannabis industry, be sure to subscribe to one or more of our free email newsletters. Also, connect with The Daily Marijuana Observer on Facebook, Twitter, StockTwits and
D/M/O
Disclaimer
Investing in nanocap, microcap, and small cap stocks is highly speculative. The publishers of DailyMarijuanaObserver.com are not registered as Investment Advisors or Broker-Dealers in any jurisdiction whatsoever. The information contained on DailyMarijuanaObserver.com (“this site”) has been prepared solely for informational purposes. Nothing on the site is an offer or solicitation to buy or sell securities. Investors should seek financial advice regarding the appropriateness of investing in any securities mentioned from their financial advisor.
]]>
5 of Today's Biggest Marijuana Stock Losers - Thursday, August 30th]]>Steven Lachardhttps://www.dailymarijuanaobserver.com/single-post/2018/08/30/5-of-Todays-Biggest-Marijuana-Stock-Losers---Thursday-August-30thhttps://www.dailymarijuanaobserver.com/single-post/2018/08/30/5-of-Todays-Biggest-Marijuana-Stock-Losers---Thursday-August-30thThu, 30 Aug 2018 20:31:28 +0000
Out of over 200+ marijuana stocks, here are just 5 of the biggest marijuana stock losers in trading on Thursday, August 30th including Auxly Cannabis Group Inc. (TSXV:XLY) (OTC:CBWTF) and more…
Auxly Cannabis Group Inc. (TSXV:XLY) (OTC:CBWTF)
dropped 5.20%
on higher than average trading volume on the OTC markets, closing the day at $0.8277 USD per share. Recently, Auxly announced that it has entered into a share purchase agreement with KGK Science Inc.
Cronos Group Inc. (TSX:CRON) (NASDAQ:CRON)
Shares of Cronos Group Inc.dropped 28.41%
on higher than average trading volume on the Nasdaq, closing the day at $9.12 USD per share. Today, Citron Research's Andrew Left, accused Cronos management of deceiving investors.
Maricann Group Inc. (CSE:MARI) (OTC:MRRCF)
dropped 7.04%
today on higher than average trading volume on the OTC markets, closing the day at $1.478 USD per share. Recently, Maricann announced that it has entered into a non-binding term sheet to form a strategic joint venture with San Martino S.S., a large scale agricultural company in the Piedmont Region of Italy.
Solis Tek Inc. (OTC:SLTK)
Shares of Solis Tek Inc.
dropped 8.80%
on higher than average trading volume on the OTC markets, closing the day at $0.829 USD per share. Recently, Solis Tek announced the additions of Peter Najarian and Tiffany Davis to its Board of Directors.
Surna Inc. (OTC:SRNA)
Shares of Surna Inc.
dropped 5.88%
on lower than average trading volume on the OTC markets, closing the day at $0.16 USD per share. Recently, Surna announced operating and financial results for the three and six months ended June 30, 2018.
Tell us which marijuana stocks burned you today! Join the conversation in our Marijuana Stock Forum!
Conclusion
Find more about today's losers by checking out their respective profiles in our global marijuana stock database via the linked tickers above. To stay up to date with important developments in the cannabis industry, be sure to subscribe to one or more of our free email newsletters. Also, connect with The Daily Marijuana Observer on Facebook, Twitter, StockTwits and Instagram!
D/M/O
Disclaimer
Investing in nanocap, microcap, and small cap stocks is highly speculative. The publishers of DailyMarijuanaObserver.com are not registered as Investment Advisors or Broker-Dealers in any jurisdiction whatsoever. The information contained on DailyMarijuanaObserver.com (“this site”) has been prepared solely for informational purposes. Nothing on the site is an offer or solicitation to buy or sell securities. Investors should seek financial advice regarding the appropriateness of investing in any securities mentioned from their financial advisor.
]]>
5 of Today's Biggest Marijuana Stock Gainers - Wednesday, August 29th]]>Steven Lachardhttps://www.dailymarijuanaobserver.com/single-post/2018/08/29/5-of-Todays-Biggest-Marijuana-Stock-Gainers---Wednesday-August-29thhttps://www.dailymarijuanaobserver.com/single-post/2018/08/29/5-of-Todays-Biggest-Marijuana-Stock-Gainers---Wednesday-August-29thWed, 29 Aug 2018 21:34:18 +0000
Out of over 200+ marijuana stocks, here are 5 of the biggest marijuana stock winners in trading on Wednesday, August 29th including Aphria Inc. (TSX:APH) (OTC:APHQF) and more...
Aphria Inc. (TSX:APH) (OTC:APHQF)
Shares of Aphria Inc.
rose 11.70% on higher than average trading volume on the OTC markets, closing the day at $12.60 USD per share. Recently, Aphria announced that it has entered into a supply agreement with the Nova Scotia Liquor Corporation.
Applied Biosciences Corp. (OTC:APPB)
rose 21.69% on higher than average trading volume on the OTC markets, closing the day at $2.30 USD per share. Recently, Applied Biosciences expanded their TherPet line with an equine care line.
Cronos Group Inc. (NASDAQ:CRON) (TSX:CRON)
rose 14.98%
on higher than average trading volume on the Nasdaq, closing the day at $12.74 USD per share. Today, Cronos Group announced that it has entered into a joint venture agreement with an affiliate of Agroidea SAS.
GrowGeneration Corp. (OTC:GRWG)
rose 17.58% on higher than average trading volume on the OTC markets, closing the day at $4.95 USD per share. Yesterday, GrowGeneration announced it signed a lease to open a 10,000 Sq. Ft. warehouse and product showroom to service the emerging legal cannabis cultivators in the State of Oklahoma.
Supreme Cannabis Company Inc. (TSXV:FIRE) (OTC:SPRWF)
rose 24.20%
on higher than average trading volume on the OTC markets, closing the day at $1.7462 USD per share. Today, Supreme announced that its shares of common stock were approved for trading on the OTCQX® Best Market operated by OTC Market Group.
Tell us which marijuana stocks put you in the green today! Join the conversation in our Marijuana Stock Forum!
Conclusion
Find more about today's gainers by checking out their respective profiles in our global marijuana stock database via the linked tickers above. To stay up to date with important developments in the cannabis industry, be sure to subscribe to one or more of our free email newsletters. Also, connect with The Daily Marijuana Observer on Facebook, Twitter, StockTwits and
D/M/O
Disclaimer
Investing in nanocap, microcap, and small cap stocks is highly speculative. The publishers of DailyMarijuanaObserver.com are not registered as Investment Advisors or Broker-Dealers in any jurisdiction whatsoever. The information contained on DailyMarijuanaObserver.com (“this site”) has been prepared solely for informational purposes. Nothing on the site is an offer or solicitation to buy or sell securities. Investors should seek financial advice regarding the appropriateness of investing in any securities mentioned from their financial advisor.
]]>
5 of Today's Biggest Marijuana Stock Losers - Wednesday, August 29th]]>Steven Lachardhttps://www.dailymarijuanaobserver.com/single-post/2018/08/29/5-of-Todays-Biggest-Marijuana-Stock-Losers---Wednesday-August-29thhttps://www.dailymarijuanaobserver.com/single-post/2018/08/29/5-of-Todays-Biggest-Marijuana-Stock-Losers---Wednesday-August-29thWed, 29 Aug 2018 20:34:18 +0000
Out of over 200+ marijuana stocks, here are just 5 of the biggest marijuana stock losers in trading on Wednesday, August 29th including CV Sciences, Inc. (OTC:CVSI) and more…
Aero Grow International, Inc. (OTC:AERO)
dropped 5.26%
on higher than average trading volume on the OTC markets, closing the day at $2.70 USD per share. Recently, Aero Grow announced results for its first quarter ended June 30, 2018.
Blue Line Protection Group, Inc. (OTC:BLPG)
Shares of Blue Line Protection Group, Inc.dropped 5.00%
on higher than average trading volume on the OTC markets, closing the day at $0.0114 USD per share. Blue Line Protection Group provides armed protection, professional compliance and investigative services, and secure transportation services to individuals, businesses and government entities. The company has not had news as of late.
CV Sciences, Inc. (OTC:CVSI)
dropped 22.65%
today on higher than average trading volume on the OTC markets, closing the day at $3.21 USD per share. Yesterday, CV Sciences responded to the current class action lawsuit against the company.
Indoor Harvest Corp. (OTC:INQD)
dropped 6.61%
on lower than average trading volume on the OTC markets, closing the day at $0.06 USD per share. Recently, Indoor Harvest announced its financial results for the three and six months ended June 30, 2018.
MassRoots, Inc. (OTC:MSRT)
Shares of MassRoots, Inc.
dropped 6.33%
on lower than average trading volume on the OTC markets, closing the day at $0.148 USD per share. Recently, MassRoots hosted a shareholder update call on Tuesday, August 14, 2018 at 4:20 pm ET.
Tell us which marijuana stocks burned you today! Join the conversation in our Marijuana Stock Forum!
Conclusion
Find more about today's losers by checking out their respective profiles in our global marijuana stock database via the linked tickers above. To stay up to date with important developments in the cannabis industry, be sure to subscribe to one or more of our free email newsletters. Also, connect with The Daily Marijuana Observer on Facebook, Twitter, StockTwits and Instagram!
D/M/O
Disclaimer
Investing in nanocap, microcap, and small cap stocks is highly speculative. The publishers of DailyMarijuanaObserver.com are not registered as Investment Advisors or Broker-Dealers in any jurisdiction whatsoever. The information contained on DailyMarijuanaObserver.com (“this site”) has been prepared solely for informational purposes. Nothing on the site is an offer or solicitation to buy or sell securities. Investors should seek financial advice regarding the appropriateness of investing in any securities mentioned from their financial advisor.
]]>
5 of Today's Biggest Marijuana Stock Gainers - Tuesday, August 28th]]>Steven Lachardhttps://www.dailymarijuanaobserver.com/single-post/2018/08/28/5-of-Todays-Biggest-Marijuana-Stock-Gainers---Tuesday-August-28thhttps://www.dailymarijuanaobserver.com/single-post/2018/08/28/5-of-Todays-Biggest-Marijuana-Stock-Gainers---Tuesday-August-28thTue, 28 Aug 2018 21:27:56 +0000
Out of over 200+ marijuana stocks, here are 5 of the biggest marijuana stock winners in trading on Tuesday, August 28th including mCig, Inc. (OTC:MCIG) and more...
Aleafia Health Inc. (TSXV:ALEF) (OTC:ALEAF)
rose 15.30% on higher than average trading volume on the OTC markets, closing the day at $0.71486 USD per share. Today, Aleafia announced the company’s 2018 Q2 fiscal results.
Applied Biosciences Corp. (OTC:APPB)
rose 11.18% on higher than average trading volume on the OTC markets, closing the day at $1.89 USD per share. Recently, Applied Biosciences expanded their TherPet line with an equine care line.
High Hampton Hldgs Corp. (CSE:HC) (OTC:HHPHF)
rose 12.30%
on lower than average trading volume on the OTC markets, closing the day at $0.4447 USD per share. Recently, High Hampton announced it had acquired 100% of all outstanding shares of HS Airway Holding, a California corporation owning the CALIGOLD Edibles brand.
Liberty Health Sciences Inc. (CSE:LHS) (OTC:LHSIF)
rose 6.04% on higher than average trading volume on the OTC markets, closing the day at $0.66 USD per share. Recently, Liberty Health Sciences announced that it has launched its much anticipated new website.
mCig, Inc. (OTC:MCIG)
Shares of mCig, Inc.
rose 8.00%
on higher than average trading volume on the OTC markets, closing the day at $0.336 USD per share. Recently, mCig announced that it would begin harvesting its first crop of organic hemp from NYAcres in two to three weeks time.
Tell us which marijuana stocks put you in the green today! Join the conversation in our Marijuana Stock Forum!
Conclusion
Find more about today's gainers by checking out their respective profiles in our global marijuana stock database via the linked tickers above. To stay up to date with important developments in the cannabis industry, be sure to subscribe to one or more of our free email newsletters. Also, connect with The Daily Marijuana Observer on Facebook, Twitter, StockTwits and
D/M/O
Disclaimer
Investing in nanocap, microcap, and small cap stocks is highly speculative. The publishers of DailyMarijuanaObserver.com are not registered as Investment Advisors or Broker-Dealers in any jurisdiction whatsoever. The information contained on DailyMarijuanaObserver.com (“this site”) has been prepared solely for informational purposes. Nothing on the site is an offer or solicitation to buy or sell securities. Investors should seek financial advice regarding the appropriateness of investing in any securities mentioned from their financial advisor.
]]>
5 of Today's Biggest Marijuana Stock Losers - Tuesday, August 28th]]>Steven Lachardhttps://www.dailymarijuanaobserver.com/single-post/2018/08/28/5-of-Todays-Biggest-Marijuana-Stock-Losers---Tuesday-August-28thhttps://www.dailymarijuanaobserver.com/single-post/2018/08/28/5-of-Todays-Biggest-Marijuana-Stock-Losers---Tuesday-August-28thTue, 28 Aug 2018 20:45:59 +0000
Out of over 200+ marijuana stocks, here are just 5 of the biggest marijuana stock losers in trading on Tuesday, August 28th including CV Sciences, Inc. (OTC:CVSI) and more…
Auxly Cannabis Group Inc. (TSXV:XLY) (OTC:CBWTF)
dropped 12.62%
on higher than average trading volume on the OTC markets, closing the day at $0.7979 USD per share. Recently, Auxly Cannabis announced that it has entered into a share purchase agreement with KGK Science Inc. to acquire all of the issued and outstanding shares of KGK.
CannTrust Holdings Inc. (TSX:TRST) (OTC:CNTTF)
Shares of CannTrust Holdings Inc.dropped 9.29%
on higher than average trading volume on the OTC markets, closing the day at $7.03 USD per share. Today, Canntrust announced that it will continue to put medical cannabis patients’ needs first and will absorb the Federal Government’s Excise Tax on medical cannabis.
CV Sciences, Inc. (OTC:CVSI)
dropped 15.99%
today on higher than average trading volume on the OTC markets, closing the day at $4.15 USD per share. Today, CV Sciences responded to the current class action lawsuit against the company.
Emerald Health Therapeutics Inc. (TSXV:EMH) (OTC:EMHTF)
dropped 9.57%
on higher than average trading volume on the OTC markets, closing the day at $3.12 USD per share. Yesterday, Emerald Health announced that it has signed a term sheet to form a strategic alliance with Factors R&D Technology, Inc.
MYM Neutraceuticals Inc. (CSE:MYM) (OTC:MYMMF)
dropped 11.50%
on higher than average trading volume on the OTC markets, closing the day at $1.00 USD per share. Recently, MYM announced it has entered into a partnership with the University of Sherbrooke to study the medicinal and industrial uses of cannabis and hemp.
Tell us which marijuana stocks burned you today! Join the conversation in our Marijuana Stock Forum!
Conclusion
Find more about today's losers by checking out their respective profiles in our global marijuana stock database via the linked tickers above. To stay up to date with important developments in the cannabis industry, be sure to subscribe to one or more of our free email newsletters. Also, connect with The Daily Marijuana Observer on Facebook, Twitter, StockTwits and Instagram!
D/M/O
Disclaimer
Investing in nanocap, microcap, and small cap stocks is highly speculative. The publishers of DailyMarijuanaObserver.com are not registered as Investment Advisors or Broker-Dealers in any jurisdiction whatsoever. The information contained on DailyMarijuanaObserver.com (“this site”) has been prepared solely for informational purposes. Nothing on the site is an offer or solicitation to buy or sell securities. Investors should seek financial advice regarding the appropriateness of investing in any securities mentioned from their financial advisor.
]]>
CannTrust to Absorb Excise Tax for Medical Cannabis Patients]]>D.M.O. Newswirehttps://www.dailymarijuanaobserver.com/single-post/2018/08/28/TRST-CannTrust-to-Absorb-Excise-Tax-for-Medical-Cannabis-Patientshttps://www.dailymarijuanaobserver.com/single-post/2018/08/28/TRST-CannTrust-to-Absorb-Excise-Tax-for-Medical-Cannabis-PatientsTue, 28 Aug 2018 17:33:33 +0000
Vaughn, ON, Aug. 28, 2018 — /D.M.O. Newswire/ — CannTrust Holdings Inc. ("CannTrust" or the "Company") (TSX:TRST), one of Canada's leading licensed producers and most trusted brands of cannabis announced today that it will continue to put medical cannabis patients' needs first and will absorb the Federal Government's Excise Tax on medical cannabis.
When Bill C-45, the Cannabis Act, received Royal Assent on June 21, 2018, it imposed an Excise Tax, being the greater of $1 per gram or 10% of the sale price of cannabis. Scheduled to come into effect on October 17, 2018, this tax is applicable for both the recreational and the medical market on all cannabis products containing THC. Continuing its commitment to affordable medicine, CannTrust has announced that it will support its medical cannabis customers by continuing to offer competitive pricing of its quality medical cannabis and that the Company will absorb the increased cost as a result of the tax.
CannTrust is also encouraging its more than 47,000 active medical cannabis customers to take a stand by signing Petition E-1528 that supports the removal of the Excise Tax on medical cannabis. All concerned Canadians can follow the link to Petition E-1528 on the Company's website at www.canntrust.ca.
"Most patients have to pay for their cannabis products directly and we want to ensure they can continue to afford their medication. If you're a CannTrust medical cannabis customer you will not have to pay more for your medical cannabis due to the upcoming Excise Tax. In addition to absorbing this tax, CannTrust remains committed to our compassionate use program which supports patients with financial needs," said Brad Rogers, President of CannTrust.
"I applaud this CannTrust decision and thank the Company for its support of cannabis patients. I am grateful that the proposed Excise Tax will not affect CannTrust's medical cannabis customers and I encourage other companies to follow their lead. It's already difficult for many patients to afford their prescriptions and an additional tax could put their treatment out-of-reach," adds Dr. Kevin Rod, Director of the Toronto Poly Clinic, a multi-disciplinary pain management Centre.
CannTrust also offers cannabis patients many other benefits. Besides quality products and competitive pricing, CannTrust medical cannabis customers get the convenience of home delivery through Canada Post and in the Greater Toronto Area, can choose same day delivery. Patients with a Health Care Spending Account (HCSA) have the opportunity to have their cannabis products covered under these plans. CannTrust Customer Care Centre is staffed with clinically trained agents and is open seven days a week to meet the needs of medical cannabis customers from coast-to-coast.
CannTrust is setting new industry productivity benchmarks thanks to the Company's first-of-its-kind, perpetual harvest greenhouse facility in Niagara, Ontario. This facility is designed to position CannTrust as one of the lowest cost producers of quality cannabis flower and will dramatically increase the Company's cost-efficiency. With this projected ability to produce at a cost-per-gram that is significantly below traditional indoor production facilities, CannTrust can ensure that its medical cannabis customers always have access to top-quality product at affordable prices.
About CannTrust
Since its inception in 2014, CannTrust has led the Canadian market in producing standardized cannabis products.
As a federally regulated licensed producer, CannTrust brings more than 40 years of pharmacy and healthcare experience to the medical cannabis industry. CannTrust currently operates the recently completed 250,000 sq. ft. Phase One redevelopment of its 450,000 sq. ft. Niagara Perpetual Harvest Facility. The 200,000 sq. ft. Phase Two redevelopment is expected to be operational in the third quarter and the projected 600,000 sq. ft. greenhouse expansion has begun and is fully funded. The industry's broadest product portfolio is prepared and packaged at the 60,000 sq. ft. manufacturing Centre of excellence in Vaughan, Ontario.
CannTrust is committed to research and innovation, as well as contributing to the growing body of evidence-based research regarding the use and efficacy of cannabis. Its product development teams along with its exclusive global pharma partner, Apotex Inc., are diligently innovating and developing products that will make it easier for patients to use medical cannabis. CannTrust supports ongoing patient education about medical cannabis and has a compassionate use program to support patients with financial needs.
For more information, please visit: www.canntrust.ca.
Forward Looking Statements
This press release contains "forward-looking information" within the meaning of applicable Canadian securities legislation which are based upon CannTrust's current internal expectations, estimates, projections, assumptions and beliefs and views of future events. Forward-looking information can be identified by the use of forward-looking terminology such as "expect", "likely", "may", "will", "should", "intend", "anticipate", "potential", "proposed", "estimate" and other similar words, including negative and grammatical variations thereof, or statements that certain events or conditions "may", "would" or "will" happen, or by discussions of strategy.
The forward-looking information in this news release is based upon the expectations, estimates, projections, assumptions and views of future events which management believes to be reasonable in the circumstances. Forward-looking information includes estimates, plans, expectations, opinions, forecasts, projections, targets, guidance or other statements that are not statements of fact. Forward-looking statements in this news release include, but are not limited to, statements with respect to internal expectations, expectations with respect to actual production volumes, expectations for future growing capacity and the completion of any capital project or expansions. Forward-looking statements necessarily involve known and unknown risks, including, without limitation, risks associated with general economic conditions; adverse industry events; loss of markets; future legislative and regulatory developments; inability to access sufficient capital from internal and external sources, and/or inability to access sufficient capital on favourable terms; the medical cannabis industry in Canada generally; the ability of CannTrust to implement its business strategies; competition; crop failure; and other risks.
Any forward-looking information speaks only as of the date on which it is made, and, except as required by law, CannTrust does not undertake any obligation to update or revise any forward-looking information, whether as a result of new information, future events or otherwise. New factors emerge from time to time, and it is not possible for CannTrust to predict all such factors. When considering these forward-looking statements, readers should keep in mind the risk factors and other cautionary statements in CannTrust's Annual Information Form dated March 29, 2018 (the "AIF") and filed with the applicable Canadian securities regulatory authorities on SEDAR at www.sedar.com. The risk factors and other factors noted in the AIF could cause actual events or results to differ materially from those described in any forward-looking information.
]]>
CROP's Wheeler Facility Commences Commercial Production]]>D.M.O. Newswirehttps://www.dailymarijuanaobserver.com/single-post/2018/08/28/CROPs-Wheeler-Facility-Commences-Commercial-Productionhttps://www.dailymarijuanaobserver.com/single-post/2018/08/28/CROPs-Wheeler-Facility-Commences-Commercial-ProductionTue, 28 Aug 2018 15:15:11 +0000
VANCOUVER, British Columbia, Aug. 28, 2018 — /D.M.O. Newswire/ — CROP Infrastructure Corp. (CSE:CROP) (OTC:CRXPF) (CROP.CN) ("CROP" or the "Company") announced today that its tenant has now commenced commercial production at Wheeler Park. The facility is designed for perpetual harvest of cannabis at 'The Park', its state-of-the-art facility in Washington State. Crop's licensed tenant grower has now advised the Company that it expects its first harvest of cannabis within weeks and it will be at full scale production in September 2018. The perpetual harvest system utilizes cannabis strains with a 55-60 day flower cycle. Every other day the tenant grower removes three trays of flowered plants from the finishing end and harvests the plants, while simultaneously loading three new trays with plants to begin the flowering process.
The Park cannabis greenhouse is 35,000 sqft and sits on approximately nine acres of land. The facility recently underwent a complete retro-fit for hydroponic automation and the addition of 500 Gavita HPS grow lights. The greenhouse facility has five flowering bays that are designed to yield, at full scale production, approximately 12,000 pounds of high quality cannabis annually (~1,000 pounds per month). The current operating cost is $50,000 USD per month.
CROP Infrastructure Director and CEO, Michael Yorke, stated: "With harvests now underway in California along with our Washington tenant weeks away from its first harvest, the Company is now at a turning point. The Company expects four of its six tenant licensees to harvest at its farms, with each set to begin cash flowing in Q4 2018."
About CROP Infrastructure Corp.
CROP Infrastructure Corp. is publicly listed on the Canadian Securities Exchange and trades under the symbol "CROP" and in the US under the symbol "CRXPF". CROP is primarily engaged in the business of investing, constructing, owning and leasing greenhouse projects as part of the provision of turnkey real estate solutions for lease-to-licensed cannabis producers and processors offering best-in-class operations. The Company's portfolio of assets includes cultivation properties in California, Washington State, Nevada, Italy, Jamaica and a joint venture on West Hollywood and San Bernardino dispensary applications. CROP has developed a portfolio of 16 Cannabis brands and has US and Italian distribution rights to a line of over 55 topical cannabis products from The Yield Growth Corp.
Disclaimer for Forward-Looking Information
Forward-looking statements are not based on historical facts, but rather on current expectations and projections about future events and are therefore subject to risks and uncertainties which could cause actual results to differ materially from the future results expressed or implied by the forward-looking statements. In addition, marijuana remains a Schedule I drug under the United States Controlled Substances Act of 1970. Although Congress has prohibited the US Justice Department from spending federal funds to interfere with the implementation of state medical marijuana laws, this prohibition must be renewed each year to remain in effect. These statements generally can be identified by the use of forward-looking words such as "may", "should", "could", "intend", "estimate", "plan", "anticipate", "expect", "believe" or "continue", or the negative thereof or similar variations. Forward-looking statements in this news release include statements regarding the expected yield from The Jamaica Property; the technological effects of The Jamaica Property on production; the intention to expand its portfolio; and execute on its business plan. Such statements are qualified in their entirety by the inherent risks and uncertainties surrounding the regulatory and legal framework regarding the cannabis industry in general among all levels of government and zoning; risks associated with applicable securities laws and stock exchange rules relating to the cannabis industry; risks associated with maintaining its interests in its various assets; the ability of the Company to finance operations and execute its business plan and other factors beyond the control of the Company. Such forward-looking statements should therefore be construed in light of such factors, and the Company is not under any obligation, and expressly disclaims any intention or obligation, to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by applicable law.
]]>
Namaste Announces Recreational Cannabis Market Strategy]]>D.M.O. Newswirehttps://www.dailymarijuanaobserver.com/single-post/2018/08/28/N-Namaste-announces-recreational-cannabis-market-strategyhttps://www.dailymarijuanaobserver.com/single-post/2018/08/28/N-Namaste-announces-recreational-cannabis-market-strategyTue, 28 Aug 2018 15:05:12 +0000
Vancouver, Aug. 28, 2018 — /D.M.O. Newswire/ — Namaste Technologies Inc. ("Namaste" or the "Company") (TSXV:N) (FRANKFURT:M5BQ) (OTC:NXTTF) is pleased to announce its new corporate strategy related to its position in the Canadian recreational cannabis marketplace. Due to much uncertainty surrounding both federal and provincial roll-outs of recreational cannabis, Namaste remained focused solely on the medical cannabis market until such time that a more transparent framework was established. Fast forward to today and it is clearly evident that there has been significant progress made with regards to the rules and regulations outlining the sale and distribution of recreational cannabis. As such, Namaste has made the decision to take a more proactive approach in an attempt to capitalize on several key areas of the recreational market.
Further to recent updates from the Provincial Government of Ontario, Namaste is extremely confident that many of its technology assets will lend themselves to improving the security and distribution of recreational cannabis online and in provincially operated dispensaries. Namaste's platforms, including its exclusive partnership with YPB Group Ltd. ("YPB") (ASX: YPB), have the potential to provide far superior authentication and security for provincially approved cannabis products. In addition, the Company's age and identity verification, with exclusive rights to its facial recognition technology, could help provide a much safer protocol for online retail platforms. Through NamasteMD, the Company has developed and acquired cutting-edge age and identity verification technology which is already in use in Namaste's platform, that would provide significant value to all consumers, through all the varying distribution channels across Canada. Namaste would like to reinforce that both platforms are already proven and in operation and would be available for immediate deployment within these applications.
In addition to these valuable authentication protocols, Namaste has also identified the need for its global customers to have confidence in the products they are purchasing, and for vendors to have access to granular data on their end-users. As such, Namaste has introduced YPB's solutions across its network of manufacturers, including Canadian Licensed Producers, to help bring certainty of authenticity and supply chain transparency to the entire legal cannabis industry globally. This coalition furthers Namaste's agenda in providing leading technology platforms for its global marketplace and for enhancing the user experience for its customers.
With YPB having recently signed 3 new customers, there is little doubt that this technology brings value to those who adopt YPB's technology. Namaste believes YPB's technology could provide a far superior solution to all provinces, especially considering the Ontario Provincial Governments decision regarding online dispensaries. The use of product QR codes would allow those who adopt the technology the ability to not only verify the authenticity of a cannabis product being provincially approved, but also provide valuable product information, including strain data and origin.
Namaste will be initiating the development of a private-label line of cannabis products through its Licensed Producer partners that will include a unique offering of premium strains and products that will be targeted to both medical and recreational markets. By securing numerous agreements with a multitude of Licensed Producers, Namaste has successfully guaranteed its supply channel on a going forward basis, and pending approval of Cannmart's sales license, the Company is well positioned to launch its fully-integrated marketplace by introducing cannabis sales into its online platform.
The Company will be actively pursuing opportunities in online recreational cannabis sales within provinces that permit. Through its partnerships with Licensed Producers, Namaste will offer a comprehensive online platform for recreational cannabis including integration of its various technology components that will bring significant value to Namaste and its partners. Namaste will also have the unique ability to offer other various technology integrations, including Pineapple Express Inc. ("Pineapple Express") same-day delivery service. With the initial launch of same-day delivery in Toronto, which represents the fourth largest city in North America, Namaste eventually plans to roll-out the service across Canada and into other major markets including Vancouver and Winnipeg.
While Namaste has laid the foundation to become Canada's leading online retailer of medicinal cannabis and will continue to focus on the medical market, the Company is now focused on expanding the scope of its platform to gain market share in the recreational space by offering the top Licensed Producer products, industry-leading technology integrations and a superior user experience.
Management Commentary
Sean Dollinger, President, and CEO of Namaste comments: "Over the past year we've been very quiet as it relates to the recreational cannabis industry. We have taken our time to see how the legislation progresses province by province. Although we are not a cultivator, we do see significant market share for the Company in providing highly valuable technology platforms to the recreational market. Furthermore, through strategic partnerships with Licensed Producers we will certainly be developing our own brand that will be sold through medical and recreational channels.
As we progress towards official legalization Namaste has never been better positioned to capitalize on both markets. Now that we have proven that our platform works, with the acceleration of our medical patients we can now work on utilizing our technology to become a leader in the recreational space.
We are very excited to see our strategy coming together and unfolding before our eyes. We'd like to thank all of our shareholders for their support and hope to see everyone at the Pledge Party September 12th.
About Namaste Technologies Inc.
Namaste Technologies is Your Everything Cannabis Store™. Namaste operates the largest global cannabis e-commerce platform with over 30 websites in 20+ countries under various brands. Namaste's product offering through its subsidiaries includes vaporizers, glassware, accessories, CBD products, and the company will soon be selling medical cannabis in the Canadian market, subject to approval by Health Canada.
Namaste has developed and acquired innovative technology platforms including NamasteMD.com, Canada's first Health Canada compliant telemedicine application, and in May 2018 the Company acquired a leading e-commerce AI and Machine Learning Company, Findify AB. Findify uses artificial intelligence algorithms to optimize and personalize a consumer's on-site buying experience. Namaste is focused on leveraging its cutting-edge technology to enhance the user experience throughout its platforms. Namaste will continue to develop and acquire innovative technologies which will provide value to the Company and to its shareholders as well as to the broader cannabis market.
On behalf of the Board of Directors
"Sean Dollinger"
Chief Executive Officer
Direct: +1 (604) 355-6100
Email: info@namastetechnologies.com
Further information on the Company and its products can be accessed through the links below:
NamasteTechnologies.com
NamasteMD.com
NamasteVapes.ca
Everyonedoesit.ca
FORWARD-LOOKING INFORMATIONThis press release contains forward-looking information based on current expectations. These statements should not be read as guarantees of future performance or results. Such statements involve known and unknown risks, uncertainties and other factors that may cause actual results, performance or achievements to be materially different from those implied by such statements. Although such statements are based on management's reasonable assumptions, Namaste assumes no responsibility to update or revise forward-looking information to reflect new events or circumstances unless required by law. Although the Company believes that the expectations and assumptions on which the forward-looking statements are based are reasonable, undue reliance should not be placed on the forward-looking statements because the Company can give no assurance that they will prove to be correct. Since forward-looking statements address future events and conditions, by their very nature they involve inherent risks and uncertainties. These statements speak only as of the date of this press release. Actual results could differ materially from those currently anticipated due to a number of factors and risks including various risk factors discussed in the Company's disclosure documents which can be found under the Company's profile on www.sedar.com. This press release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. The TSXV has neither reviewed nor approved the contents of this press release.
]]>
5 of Today's Biggest Marijuana Stock Gainers - Monday, August 27th]]>Steven Lachardhttps://www.dailymarijuanaobserver.com/single-post/2018/08/27/5-of-Todays-Biggest-Marijuana-Stock-Gainers---Monday-August-27thhttps://www.dailymarijuanaobserver.com/single-post/2018/08/27/5-of-Todays-Biggest-Marijuana-Stock-Gainers---Monday-August-27thMon, 27 Aug 2018 21:06:17 +0000
Out of over 200+ marijuana stocks, here are 5 of the biggest marijuana stock winners in trading on Monday, August 27th including Aphria Inc. (TSX:APH) (OTC:APHQF) and more...
Aphria Inc. (TSX:APH) (OTC:APHQF)
Shares of Aphria Inc.
rose 8.53% on higher than average trading volume on the OTC markets, closing the day at $11.67 USD per share. Recently, it was rumored that Aphria was going to be chosen as Diageo’s Canadian cannabis partner.
Aurora Cannabis Inc. (TSX:ACB) (OTC:ACBFF)
rose 7.74% on higher than average trading volume on the OTC markets, closing the day at $7.10 USD per share. Today, Aurora reaffirmed its commitment to advocating for the amnesty of cannabis possession offenses through a $50,000 contribution to the Campaign for Cannabis Amnesty.
Cronos Group Inc. (TSX:CRON) (NASDAQ:CRON)
rose 21.13%
on higher than average trading volume on the Nasdaq, closing the day at $12.04 USD per share. Recently, Cronos Group announced its initial supply agreements for retail distribution, both government-operated and private, across Canada.
The Hydropothecary Corporation (TSX:HEXO) (OTC:HYYDF)
rose 6.80% on higher than average trading volume on the OTC markets, closing the day at $4.35 USD per share. Recently, Hydropothecary announced the company was celebrating its fifth anniversary and recently surpassed 200 employees.
India Globalization Capital, Inc. (NYSE:IGC)
rose 114.11%
on higher than average trading volume on the NYSE, closing the day at $1.52 USD per share. Recently, IGC announced that it has designated California as a priority market for Hyalolex, its lead cannabis-based supplement for treating and managing Alzheimer’s patients.
Tell us which marijuana stocks put you in the green today! Join the conversation in our Marijuana Stock Forum!
Conclusion
Find more about today's gainers by checking out their respective profiles in our global marijuana stock database via the linked tickers above. To stay up to date with important developments in the cannabis industry, be sure to subscribe to one or more of our free email newsletters. Also, connect with The Daily Marijuana Observer on Facebook, Twitter, StockTwits and
D/M/O
Disclaimer
Investing in nanocap, microcap, and small cap stocks is highly speculative. The publishers of DailyMarijuanaObserver.com are not registered as Investment Advisors or Broker-Dealers in any jurisdiction whatsoever. The information contained on DailyMarijuanaObserver.com (“this site”) has been prepared solely for informational purposes. Nothing on the site is an offer or solicitation to buy or sell securities. Investors should seek financial advice regarding the appropriateness of investing in any securities mentioned from their financial advisor.
]]>
5 of Today's Biggest Marijuana Stock Losers - Monday, August 27th]]>Steven Lachardhttps://www.dailymarijuanaobserver.com/single-post/2018/08/27/5-of-Todays-Biggest-Marijuana-Stock-Losers---Monday-August-27thhttps://www.dailymarijuanaobserver.com/single-post/2018/08/27/5-of-Todays-Biggest-Marijuana-Stock-Losers---Monday-August-27thMon, 27 Aug 2018 20:46:51 +0000
Out of over 200+ marijuana stocks, here are just 5 of the biggest marijuana stock losers in trading on Monday, August 27th including CV Sciences, Inc. (OTC:CVSI) and more…
Acology Inc. (OTC:ACOL)
Shares of Acology Inc.
dropped 8.26%
on higher than average trading volume on the OTC markets, closing the day at $0.01 USD per share. Recently, Acology latest quarterly report was released.
Bang Holdings Corp. (OTC:BXNG)
dropped 15.35%
on higher than average trading volume on the OTC markets, closing the day at $0.4401 USD per share. Recently, Bang Holdings announced that the Company has entered into an Exclusive Development Agreement with The Arcview Group.
Blue Line Protection Group, Inc. (OTC:BLPG)
dropped 14.41%
on higher than average trading volume on the OTC markets, closing the day at $0.0101 USD per share. Blue Line Protection Group provides armed protection, professional compliance and investigative services, and secure transportation services to individuals, businesses and government entities.
CV Sciences, Inc. (OTC:CVSI)
dropped 21.21%
today on higher than average trading volume on the OTC markets, closing the day at $4.94 USD per share. Recently, it was announced that a securities class action law suit was filed against CV Sciences, Inc.
Golden Leaf Holdings Ltd. (CSE:GLH) (OTC:GLDFF)
dropped 4.41%
on higher than average trading volume on the OTC markets, closing the day at $0.2103 USD per share. Recently, Golden Leaf announced that it will report its financial results for the quarter ended June 30, 2018 on Wednesday, August 29, 2018, after market-close.
Tell us which marijuana stocks burned you today! Join the conversation in our Marijuana Stock Forum!
Conclusion
Find more about today's losers by checking out their respective profiles in our global marijuana stock database via the linked tickers above. To stay up to date with important developments in the cannabis industry, be sure to subscribe to one or more of our free email newsletters. Also, connect with The Daily Marijuana Observer on Facebook, Twitter, StockTwits and Instagram!
D/M/O
Disclaimer
Investing in nanocap, microcap, and small cap stocks is highly speculative. The publishers of DailyMarijuanaObserver.com are not registered as Investment Advisors or Broker-Dealers in any jurisdiction whatsoever. The information contained on DailyMarijuanaObserver.com (“this site”) has been prepared solely for informational purposes. Nothing on the site is an offer or solicitation to buy or sell securities. Investors should seek financial advice regarding the appropriateness of investing in any securities mentioned from their financial advisor.
]]>
CannaRoyalty Completes Strategic Sale of AltMed for $8 Million]]>D.M.O. Newswirehttps://www.dailymarijuanaobserver.com/single-post/2018/08/27/CRZ-CannaRoyalty-Completes-Strategic-Sale-of-AltMed-for-8-Millionhttps://www.dailymarijuanaobserver.com/single-post/2018/08/27/CRZ-CannaRoyalty-Completes-Strategic-Sale-of-AltMed-for-8-MillionMon, 27 Aug 2018 14:13:06 +0000
OTTAWA, Aug. 27, 2018 — /D.M.O. Newswire/ — CannaRoyalty Corp.(CSE:CRZ) (OTC:CNNRF) ("CannaRoyalty"), a leading North American cannabis products and brands company, today announced that it has entered into a binding letter of intent (the "Agreement") with Tidal Royalty Corp. ("Tidal Royalty"), a leading provider of royalty financing to licensed U.S. cannabis operators, whereby Tidal Royalty will acquire the Company's equity stake and royalty entitlement in Alternative Medical Enterprises LLC ("AltMed") for a consideration of $8 million. CannaRoyalty will maintain the right to license MÜV products in California, Nevada, Canada and other select markets.
AltMed is a licensed cannabis business operating in the state of Florida that exclusively manufactures and distributes a line of award-winning cannabis infused products marketed under the MÜV™ brand. NuTrae (doing business as MüV), is a subsidiary of AltMed and launched the MüV product line in Q3, 2016 exclusively in the Arizona medical market. As previously disclosed, CannaRoyalty currently holds an 6.14% ownership position in AltMed and has a 3.5% royalty on global net sales of the following MüV products: Transdermal patches, metered dose inhalers, and patent-pending transdermal gels.
"The sale of our equity stake and royalty in AltMed advances our stated strategy of realizing value for shareholders on assets that are deemed non-core to our business. The substantial gains from our successful investment in AltMed will provide CannaRoyalty with capital to continue to expand its distribution and brand network in the California market, while offering CannaRoyalty shareholders a significant return on investment," said Marc Lustig, Chairman and CEO of CannaRoyalty.
"We were early to identify the long term potential in AltMed and MüV as vital players in the North American cannabis value chain and are confident that the businesses will be valuable additions to Tidal Royalty's diverse portfolio. As CannaRoyalty continues to grow and build a solid presence in California, we look forward to partnering with the experienced team at Tidal Royalty." Mr. Lustig added.
The aggregate consideration of $8 million will be in a combination of cash and Tidal Royalty's stock. Closing of the transaction is subject to, among other things, the satisfactory completion of due diligence, which is currently underway, and the receipt of all corporate and regulatory approvals.
About CannaRoyalty
CannaRoyalty is a North American cannabis consumer product company currently focused on building a leading distribution business in California, the world's largest regulated cannabis market. By building a world-class logistics platform and supporting contract manufacturing assets, the Company intends to support the growth of new and established cannabis brands. The Company believes California, home to some of the world's most discerning consumers and a nexus of information and trends, will be the point of inception for the global cannabis brands of the future. CannaRoyalty has developed a diversified portfolio of assets within the cannabis sector, including research, infrastructure and intellectual property to support our existing brands, partner products and distribution networks. The Company's leadership and staff combines passion and a hands-on understanding of the cannabis industry, with proven financial and legal expertise. CannaRoyalty's shares trade on the Canadian Stock Exchange (CSE) under the symbol CRZ and in the US on the OTCQX under the symbol CNNRF.
Forward Looking Statements
Statements in this news release that are forward-looking statements are subject to various risks and uncertainties concerning the specific factors disclosed here and elsewhere in CannaRoyalty's periodic filings with Canadian securities regulators. When used in this news release, words such as "will, could, plan, estimate, expect, intend, may, potential, believe, should," and similar expressions, are forward- looking statements.
Forward-looking statements may include, without limitation, anticipated timing for the Company's release of financial results, the execution of the Company's strategy, new opportunities, future growth and other statements.
Forward‐looking statements involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of CannaRoyalty, its subsidiaries, or its affiliates to be materially different from any future results, performance or achievements expressed or implied by the forward‐looking statements. Although CannaRoyalty has attempted to identify important factors that could cause actual results, performance or achievements to differ materially from those contained in the forward-looking statements, there can be other factors and assumptions that cause results, performance or achievements not to be as anticipated, estimated or intended, including, but not limited to: dependence on obtaining regulatory approvals; investing in target companies or projects that are engaged in activities currently considered illegal under US federal law; changes in laws; limited operating history; reliance on management; requirements for additional financing; competition; hindering market growth and state adoption due to inconsistent public opinion and perception of the medical-use and adult-use marijuana industry and; regulatory or political change.
There can be no assurance that such information will prove to be accurate or that management's expectations or estimates of future developments, circumstances or results will materialize. As a result of these risks and uncertainties, the results or events predicted in these forward-looking statements may differ materially from actual results or events.
Accordingly, readers should not place undue reliance on forward-looking statements. The forward-looking statements in this news release are made as of the date of this release. CannaRoyalty disclaims any intention or obligation to update or revise such information, except as required by applicable law, and CannaRoyalty does not assume any liability for disclosure relating to any other company mentioned herein.
]]>
Namaste Announces Supply Agreement with GTEC Holdings]]>D.M.O. Newswirehttps://www.dailymarijuanaobserver.com/single-post/2018/08/27/Namaste-Announces-Supply-Agreement-with-GTEC-Holdingshttps://www.dailymarijuanaobserver.com/single-post/2018/08/27/Namaste-Announces-Supply-Agreement-with-GTEC-HoldingsMon, 27 Aug 2018 13:32:56 +0000
VANCOUVER, Aug. 27, 2018 — /D.M.O. Newswire/ — Namaste Technologies Inc. ("Namaste" or the "Company") (TSXV:N) (FRANKFURT:M5BQ) (OTC:NXTTF) is pleased to announce that the Company has signed a bulk cannabis supply agreement (the "Supply Agreement") with GTEC Holdings Ltd. ("GTEC") (TSXV:GTEC) (OTC:GGTTF), whereby Namaste's wholly owned subsidiary and Health Canada's Access to Cannabis for Medical Purposes ("ACMPR") late-stage applicant, Cannmart Inc. ("Cannmart") will purchase bulk cannabis flower and oil from GTEC for resale in Cannmart's online platform. Cannmart will be Canada's first ACMPR Licensed Producer ("LP") with a "sales-only" license, allowing the Company to leverage its e-commerce expertise to become Canada's leading cannabis online retailer.
This Supply Agreement further demonstrates Namaste's ability to secure a strong supply chain to help service Namaste's growing list of patients, and execute on its strategy to create Canada's largest online retail cannabis platform. GTEC is a Kelowna-based LP which owns and operates several cultivation facilities, and Namaste anticipates GTEC becoming a key supplier for Cannmart's platform. With the upcoming roll-out of recreational cannabis and with an anticipated short-term national supply shortage, cannabis supply agreements are now more important than ever to Namaste's long-term strategy. This Supply Agreement further demonstrates Namastes ability to secure a strong supply chain with multiple LP's.
Namaste's e-commerce platform and technology will continue to drive innovation that will have a major impact on the way in which patients can access medical cannabis online. Namaste's goal is to create the most comprehensive user experience possible by personalizing product and strain recommendations through the integration of its AI technology, by providing convenient access to healthcare practitioners, and by driving cannabis sales through Cannmart.
With the recent launch of NamsteMD's ("NamasteMD.com") Google Android App, the company expects to see exponential growth having recently reached over 14,000 registered users. The continuous acceleration and strong supply channels have Namaste well-positioned to integrate cannabis sales within its e-commerce platform. The Company has been overwhelmed with support from its LP partners who see Namaste's vision to become the global leader in online retail for all things cannabis.
Management Commentary
Norton Singhavon, Chairman and CEO of GTEC comments: "GTEC is actively pursuing long-term supply agreements with Licensed Producers whose core competencies are complementary to our own. Accordingly, we are very excited about our partnership with CannMart and Namaste. We believe that GreenTec's ability to cultivate and market high-quality craft cannabis provides an excellent fit with Cannmart's packaging and distribution capabilities, and Namaste's ability to develop a robust network of medical cannabis patients".
Sean Dollinger, President, and CEO of Namaste comments: "We have been working on securing this Supply Agreement with GTEC for several months and are thrilled to see this come together nicely. GTEC operates multiple facilities and will be launching a new production facility in Kelowna shortly. We're pleased to have secured another strong supplier for Cannmart.
We're expecting to receive our sales license very soon and are highly focused on expansion of our patient network and in curating a high-quality offering of cannabis products for our customers. During a time where inventory remains on shortage with many vendors, we are proud to have partners like GTEC who see value in the platform which we've created. Thanks to GTEC's management team for supporting Namaste in its efforts to become Canada's leading online cannabis retailer and we're looking forward to a strong partnership together"
About GTEC Holdings Inc.
GTEC was founded in 2017 to capitalize on opportunities in the nascent and rapidly growing legal cannabis industry. GTEC is focused on growing premium quality craft cannabis in purpose-built indoor facilities. The Company also has a number of retail cannabis initiatives in Western Canada. GTEC currently holds a 100% interest in GreenTec Bio-Pharmaceuticals Corp., Tumbleweed Farms Corp., Falcon Ridge Naturals Ltd., Alberta Craft Cannabis Inc., Grey Bruce Farms Inc., Zenalytic Laboratories Ltd. and Spectre Labs Inc. GTEC is a publicly-traded corporation based in Kelowna, British Columbia. The Company's shares are listed on the TSX Venture Exchange and OTC Pink Sheets.
About Namaste Technologies Inc.
Namaste Technologies is Your Everything Cannabis Store™. Namaste operates the largest global cannabis e-commerce platform with over 30 websites in 20+ countries under various brands. Namaste's product offering through its subsidiaries includes vaporizers, glassware, accessories, CBD products, and the company will soon be selling medical cannabis in the Canadian market, subject to approval by Health Canada.
Namaste has developed and acquired innovative technology platforms including NamasteMD.com, Canada's first Health Canada compliant telemedicine application, and in May 2018 the Company acquired a leading e-commerce AI and Machine Learning Company, Findify AB. Findify uses artificial intelligence algorithms to optimize and personalize a consumer's on-site buying experience. Namaste is focused on leveraging its cutting-edge technology to enhance the user experience throughout its platforms. Namaste will continue to develop and acquire innovative technologies which will provide value to the Company and to its shareholders as well as to the broader cannabis market.
On behalf of the Board of Directors
"Sean Dollinger"
Chief Executive Officer
Direct: +1 (604) 355-6100
Email: info@namastetechnologies.com
Further information on the Company and its products can be accessed through the links below:
NamasteTechnologies.com
NamasteMD.com
NamasteVapes.ca
Everyonedoesit.ca
FORWARD-LOOKING INFORMATION This press release contains forward-looking information based on current expectations. These statements should not be read as guarantees of future performance or results. Such statements involve known and unknown risks, uncertainties and other factors that may cause actual results, performance or achievements to be materially different from those implied by such statements. Although such statements are based on management's reasonable assumptions, Namaste assumes no responsibility to update or revise forward-looking information to reflect new events or circumstances unless required by law. Although the Company believes that the expectations and assumptions on which the forward-looking statements are based are reasonable, undue reliance should not be placed on the forward-looking statements because the Company can give no assurance that they will prove to be correct. Since forward-looking statements address future events and conditions, by their very nature they involve inherent risks and uncertainties. These statements speak only as of the date of this press release. Actual results could differ materially from those currently anticipated due to a number of factors and risks including various risk factors discussed in the Company's disclosure documents which can be found under the Company's profile on www.sedar.com. This press release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. The TSXV has neither reviewed nor approved the contents of this press release.
]]>
5 of Today's Biggest Marijuana Stock Gainers - Friday, August 24th]]>Steven Lachardhttps://www.dailymarijuanaobserver.com/single-post/2018/08/24/5-of-Todays-Biggest-Marijuana-Stock-Gainers---Friday-August-24thhttps://www.dailymarijuanaobserver.com/single-post/2018/08/24/5-of-Todays-Biggest-Marijuana-Stock-Gainers---Friday-August-24thFri, 24 Aug 2018 22:21:10 +0000
Out of over 200+ marijuana stocks, here are 5 of the biggest marijuana stock winners in trading on Friday, August 24th including Aphria Inc. (TSX:APH) (OTC:APHQF) and more...
Aphria Inc. (TSX:APH) (OTC:APHQF)
Shares of Aphria Inc.
rose 23.30% on higher than average trading volume on the OTC markets, closing the day at $10.753 USD per share. Today, it was rumored that Aphria was going to be chosen as Diageo’s Canadian cannabis partner.
CannTrust Holdings Inc. (TSX:TRST) (OTC:CNTTF)
rose 16.25% on higher than average trading volume on the OTC markets, closing the day at $7.382 USD per share. Recently, CannTrust announced thelaunch of liiv, Xscape and Synr.g, available across the country when the market opens on October 17.
Cronos Group Inc. (TSX:CRON) (NASDAQ:CRON)
rose 16.39%
on higher than average trading volume on the Nasdaq, closing the day at $9.94 USD per share. Recently, Cronos Group announced its initial supply agreements for retail distribution, both government-operated and private, across Canada.
Helix TCS, Inc. (OTC:HLIX)
Shares of Helix TCS, Inc.
rose 7.69% on higher than average trading volume on the OTC markets, closing the day at $1.40 USD per share. Today, it was announced that Director of Government Affairs of Helix's subsidiary BioTrackTHC, Daniel Sparks, J.D. will be presenting at the U.S. Cannabis Conference & Expo.
MYM Neutraceuticals Inc. (CSE:MYM) (OTC:MYMMF)
rose 19.52%
on higher than average trading volume on the OTC markets, closing the day at $0.9562 USD per share. Today, MYM announced it has entered into a partnership with the University of Sherbrooke.
Tell us which marijuana stocks put you in the green today! Join the conversation in our Marijuana Stock Forum!
Conclusion
Find more about today's gainers by checking out their respective profiles in our global marijuana stock database via the linked tickers above. To stay up to date with important developments in the cannabis industry, be sure to subscribe to one or more of our free email newsletters. Also, connect with The Daily Marijuana Observer on Facebook, Twitter, StockTwits and
D/M/O
Disclaimer
Investing in nanocap, microcap, and small cap stocks is highly speculative. The publishers of DailyMarijuanaObserver.com are not registered as Investment Advisors or Broker-Dealers in any jurisdiction whatsoever. The information contained on DailyMarijuanaObserver.com (“this site”) has been prepared solely for informational purposes. Nothing on the site is an offer or solicitation to buy or sell securities. Investors should seek financial advice regarding the appropriateness of investing in any securities mentioned from their financial advisor.
]]>
5 of Today's Biggest Marijuana Stock Losers - Friday, August 24th]]>Steven Lachardhttps://www.dailymarijuanaobserver.com/single-post/2018/08/24/5-of-Todays-Biggest-Marijuana-Stock-Losers---Friday-August-24thhttps://www.dailymarijuanaobserver.com/single-post/2018/08/24/5-of-Todays-Biggest-Marijuana-Stock-Losers---Friday-August-24thFri, 24 Aug 2018 21:54:03 +0000
Out of over 200+ marijuana stocks, here are just 5 of the biggest marijuana stock losers in trading on Friday August 24th including MariMed Inc. (OTC:MRMD) and more…
General Cannabis Corp. (OTC:CANN)
dropped 6.15%
today on higher than average trading volume on the OTC markets, closing the day at $3.05 USD per share. Recently, General Cannabis announced financial results for the quarter ended June 30, 2018.
Heliospectra AB. (OTC:HLSPY)
dropped 12.05%
on higher than average trading volume on the OTC markets, closing the day at $0.80 USD per share. Today, Heliospectra presented the Half Year Report for 2018.
Indoor Harvest Corp. (OTC:INQD)
dropped 11.76%
on higher than average trading volume on the OTC markets, closing the day at $0.06 USD per share. Today, Indoor Harvest announced its financial results for the three and six months ended June 30, 2018, and provided a business update.
MariMed Inc. (OTC:MRMD)
Shares of MariMed Inc.
dropped 6.64% on higher than average trading volume on the OTC markets, closing the day at $2.67 USD per share. Recently, Marimed reported Q2 2018 financial results.
United Cannabis Corp. (OTC:CNAB)
Shares of United Cannabis Corp.dropped 15.37% on higher than average trading volume on the OTC markets, closing the day at $0.60 USD per share. Recently, United Cannabis announced that it has initiated clinical trials on its Prana Bio Nutrient Medicinals P1 Capsules for the treatment of chronic pain at Jamaica's University of the West Indies.
Tell us which marijuana stocks burned you today! Join the conversation in our Marijuana Stock Forum!
Conclusion
Find more about today's losers by checking out their respective profiles in our global marijuana stock database via the linked tickers above. To stay up to date with important developments in the cannabis industry, be sure to subscribe to one or more of our free email newsletters. Also, connect with The Daily Marijuana Observer on Facebook, Twitter, StockTwits and Instagram!
D/M/O
Disclaimer
Investing in nanocap, microcap, and small cap stocks is highly speculative. The publishers of DailyMarijuanaObserver.com are not registered as Investment Advisors or Broker-Dealers in any jurisdiction whatsoever. The information contained on DailyMarijuanaObserver.com (“this site”) has been prepared solely for informational purposes. Nothing on the site is an offer or solicitation to buy or sell securities. Investors should seek financial advice regarding the appropriateness of investing in any securities mentioned from their financial advisor.
]]>
5 of Today's Biggest Marijuana Stock Gainers - Thursday, August 23rd]]>Steven Lachardhttps://www.dailymarijuanaobserver.com/single-post/2018/08/23/5-of-Todays-Biggest-Marijuana-Stock-Gainers---Thursday-August-23rdhttps://www.dailymarijuanaobserver.com/single-post/2018/08/23/5-of-Todays-Biggest-Marijuana-Stock-Gainers---Thursday-August-23rdThu, 23 Aug 2018 21:35:21 +0000
Out of over 200+ marijuana stocks, here are 5 of the biggest marijuana stock winners in trading on Thursday, August 23rd including Auxly Cannabis Group Inc. (TSXV:XLY) (OTC:CBWTF) and more...
Auxly Cannabis Group Inc. (TSXV:XLY) (OTC:CBWTF)
rose 14.13% on higher than average trading volume on the OTC markets, closing the day at $0.7538 USD per share. Recently, Auxly announced that it has entered into a share purchase agreement with KGK Science Inc. to acquire all of the issued and outstanding shares of KGK.
Golden Leaf Holdings Ltd. (CSE:GLH) (OTC:GLDFF)
rose 5.69% on higher than average trading volume on the OTC markets, closing the day at $0.23041 USD per share. Recently, Golden Leaf announced that it will report its financial results for the quarter ended June 30, 2018 on Wednesday, August 29, 2018, after market-close.
MassRoots, Inc. (OTC:MSRT)
Shares of MassRoots, Inc.
rose 19.20%
on higher than average trading volume on the OTC markets, closing the day at $0.149 USD per share. Recently, MassRoots provide an update on the roll-out of its dispensary portal, insight on recent and upcoming developments at the Company and key milestones for the fourth quarter of 2018.
Namaste Technologies Inc. (TSXV:N) (OTC:NXTTF)
rose 15.22% on higher than average trading volume on the OTC markets, closing the day at $1.319 USD per share. Yesterday, Namaste announced that it has signed a definitive revenue sharing agreement with Cannvas MedTech Inc.
Solis Tek Inc. (OTC:SLTK)
Shares of Solis Tek Inc.
rose 11.49%
on higher than average trading volume on the OTC markets, closing the day at $0.825 USD per share. Today, Solis Tek announced the additions of Peter Najarian and Tiffany Davis to its Board of Directors.
Tell us which marijuana stocks put you in the green today! Join the conversation in our Marijuana Stock Forum!
Conclusion
Find more about today's gainers by checking out their respective profiles in our global marijuana stock database via the linked tickers above. To stay up to date with important developments in the cannabis industry, be sure to subscribe to one or more of our free email newsletters. Also, connect with The Daily Marijuana Observer on Facebook, Twitter, StockTwits and
D/M/O
Disclaimer
Investing in nanocap, microcap, and small cap stocks is highly speculative. The publishers of DailyMarijuanaObserver.com are not registered as Investment Advisors or Broker-Dealers in any jurisdiction whatsoever. The information contained on DailyMarijuanaObserver.com (“this site”) has been prepared solely for informational purposes. Nothing on the site is an offer or solicitation to buy or sell securities. Investors should seek financial advice regarding the appropriateness of investing in any securities mentioned from their financial advisor.
]]>
5 of Today's Biggest Marijuana Stock Losers - Thursday, August 23rd]]>Steven Lachardhttps://www.dailymarijuanaobserver.com/single-post/2018/08/23/5-of-Todays-Biggest-Marijuana-Stock-Losers---Thursday-August-23rdhttps://www.dailymarijuanaobserver.com/single-post/2018/08/23/5-of-Todays-Biggest-Marijuana-Stock-Losers---Thursday-August-23rdThu, 23 Aug 2018 21:04:49 +0000
Out of over 200+ marijuana stocks, here are just 5 of the biggest marijuana stock losers in trading on Thursday, August 23rd including CV Sciences, Inc. (OTC:CVSI) and more…
CV Sciences, Inc. (OTC:CVSI)
dropped 8.56%
today on higher than average trading volume on the OTC markets, closing the day at $6.52 USD per share. Yesterday, CVSI announced that it had fully repaid its promissory note payable to Wiltshire, LLC.
Kaya Holdings, Inc. (OTC:KAYS)
dropped 7.76%
on higher than average trading volume on the OTC markets, closing the day at $0.12 USD per share. Recently, Kaya Holdings filed its quarterly report.
Naturally Splendid Enterprises Ltd. (TSXV:NSP) (OTC:NSPDF)
dropped 11.89%
on higher than average trading volume on the OTC markets, closing the day at $0.10 USD per share. Today, Naturally Splendid announced its financial results for the six months ended June 30, 2018.
Newstrike Brands Ltd. (TSXV:HIP) (OTC:NWKRF)
dropped 7.14% on higher than average trading volume on the OTC markets, closing the day at $0.541 USD per share. Recently, Newstrike announced that its wholly-owned subsidiary, Up Cannabis Inc., has entered into an agreement naming it to the list of official suppliers to the Ontario Cannabis Store.
United Cannabis Corp. (OTC:CNAB)
Shares of United Cannabis Corp.dropped 7.92% on higher than average trading volume on the OTC markets, closing the day at $0.709 USD per share. Recently, United Cannabis announced that it has initiated clinical trials on its Prana Bio Nutrient Medicinals P1 Capsules for the treatment of chronic pain at Jamaica's University of the West Indies.
Tell us which marijuana stocks burned you today! Join the conversation in our Marijuana Stock Forum!
Conclusion
Find more about today's losers by checking out their respective profiles in our global marijuana stock database via the linked tickers above. To stay up to date with important developments in the cannabis industry, be sure to subscribe to one or more of our free email newsletters. Also, connect with The Daily Marijuana Observer on Facebook, Twitter, StockTwits and Instagram!
D/M/O
Disclaimer
Investing in nanocap, microcap, and small cap stocks is highly speculative. The publishers of DailyMarijuanaObserver.com are not registered as Investment Advisors or Broker-Dealers in any jurisdiction whatsoever. The information contained on DailyMarijuanaObserver.com (“this site”) has been prepared solely for informational purposes. Nothing on the site is an offer or solicitation to buy or sell securities. Investors should seek financial advice regarding the appropriateness of investing in any securities mentioned from their financial advisor.
]]>
Emerald and Village Farms to Double Pure Sunfarms’ Cultivation Capacity]]>D.M.O. Newswirehttps://www.dailymarijuanaobserver.com/single-post/2018/08/23/EMH-VFF-Emerald-and-Village-Farms-to-Double-Pure-SunfarmsE28099-Cultivation-Capacityhttps://www.dailymarijuanaobserver.com/single-post/2018/08/23/EMH-VFF-Emerald-and-Village-Farms-to-Double-Pure-SunfarmsE28099-Cultivation-CapacityThu, 23 Aug 2018 17:03:27 +0000
Victoria, B.C. — August 23, 2018 — /D.M.O. Newswire/ — Emerald Health Therapeutics, Inc. (TSXV:EMH) (OTC:EMHTF) (“Emerald”) and Village Farms International, Inc. (TSX:VFF) (OTC:VFFIF) today announced that their 50/50 joint venture for large-scale, low-cost, high-quality cannabis production, Pure Sunfarms, received from Health Canada its third amendment to the cultivation license for its Delta 3 greenhouse in Delta, BC. This amendment permits Pure Sunfarms to expand its cannabis production area by 195,000 square feet to approximately 420,000 square feet of the 1.1-million square foot Delta 3 production facility. The newly licensed area will be in commercial production this week, as the Delta 3 nursery has been producing cuttings in anticipation of this expansion.
“We look forward to completing our build-out over the next months,” said Chris Wagner, CEO of Emerald. “As October 17th quickly approaches, we are prepared for significant sales growth and leveraging the potential of this large, highly optimized growing facility.”
“We are thrilled with the rapid pace at which the Pure Sunfarms team continues to complete conversion of additional production area, as well as the rapid pace at which it has been able to secure amendments to its cultivation license to steadily expand production,” said Michael DeGiglio, CEO of Village Farms. “It’s a testament to the value of decades of large-scale operational experience combined with an unwavering approach to doing things the right way.”
Pure Sunfarms expects to have the full 1.1 million square foot Delta 3 facility, one of the single largest cannabis growing facilities in the world, converted for cannabis production by year end. The technologically-advanced Delta 3 greenhouse design is based on decades of large-scale, low-cost agricultural production experience and extensive cannabis expertise, resulting in a state-of-the-art facility with 17 grow rooms (seven of which are now licensed) optimized for year-round harvesting (more than 85 harvests annually) and an automated process line encompassing harvesting, trimming, drying and packaging.
About Village Farms International, Inc.
Village Farms International, Inc. is one of the largest and longest-operating vertically integrated greenhouse growers in North America and the only publicly traded greenhouse produce company in Canada. With more than 750 years of accumulated master grower experience coupled with advanced proprietary technology and environmentally sustainable growing practices, Village Farms is highly resource efficient. Village Farms produces and distributes fresh, premium-quality produce with consistency 365-days a year to national grocers in the U.S. and Canada from its large-scale Controlled Environment Agriculture (CEA) greenhouses in British Columbia and Texas, as well as from its partner greenhouses in BC, Ontario, and Mexico.
About Emerald Health Therapeutics, Inc.
Emerald Health Therapeutics (TSXV: EMH; OTCQX: EMHTF; Frankfurt: TBD) is licensed in Canada to produce and sell dried cannabis and cannabis oil for medical purposes. Emerald is preparing to serve the fully legalized Canadian adult-use cannabis market starting October 17, 2018. Emerald owns 50% of Pure Sunfarms, which is converting a licensed existing 1.1 million square foot greenhouse in Delta, BC and is now in commercial production. It owns Agro-Biotech, a Québec-based licensed cannabis grower with a 75,000 square foot indoor facility and is planning to add a 500,000 square foot greenhouse in Metro Vancouver. Emerald’s team is highly experienced in life sciences, product development, large-scale agri-business, and marketing, and is focused on developing value-added cannabis-based products with potential wellness and medical benefits. Emerald is part of the Emerald Health group, which is broadly focused on developing pharmaceutical, botanical, and nutraceutical products that may provide wellness and medical benefits by interacting with the human body’s endocannabinoid system.
Please visit www.emeraldhealth.ca for more information or contact:
Rob Hill, Chief Financial Officer (800) 757 3536 Ext. #5
Ray Lagace, Investor Relations Manager (800) 757 3536 Ext. #5 invest@emeraldhealth.ca
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
Cautionary Note Regarding Forward-Looking Statements: Certain statements made in this press release that are not historical facts are forward-looking statements and are subject to important risks, uncertainties and assumptions, both general and specific, which give rise to the possibility that actual results or events could differ materially from our expectations expressed in or implied by such forward-looking statements. Such statements include legalization of nonmedicinal cannabis; production capacity of various facilities; expansion of facilities; and anticipated production costs.
We cannot guarantee that any forward-looking statement will materialize, and readers are cautioned not to place undue reliance on these forward-looking statements. These forward-looking statements involve risks and uncertainties related to, among other things, failure to obtain regulatory approvals; failure to obtain necessary financing; results of production and sale activities; results of scientific research; regulatory changes; changes in prices and costs of inputs; demand for labour; demand for products; as well as the risk factors described in the Company’s annual information form and other regulatory filings. The forward-looking statements contained in this press release represent our expectations as of the date hereof. Forward-looking statements are presented for the purpose of providing information about management’s current expectations and plans and allowing investors and others to obtain a better understanding of our anticipated operating environment. Readers are cautioned that such information may not be appropriate for other purposes. The Company undertakes no obligations to update or revise such statements to reflect new circumstances or unanticipated events as they occur, unless required by applicable law.
]]>
Tilray, Inc. to Present at the Barclays Global Consumer Staples Conference]]>D.M.O. Newswirehttps://www.dailymarijuanaobserver.com/single-post/2018/08/23/TLRY-Tilray-Inc-to-Present-at-the-Barclays-Global-Consumer-Staples-Conferencehttps://www.dailymarijuanaobserver.com/single-post/2018/08/23/TLRY-Tilray-Inc-to-Present-at-the-Barclays-Global-Consumer-Staples-ConferenceThu, 23 Aug 2018 15:46:27 +0000
Nanaimo, British Columbia — /D.M.O. Newswire/ — Tilray, Inc., (“Tilray” or the “Company”) (NASDAQ:TLRY) a global pioneer in cannabis production and distribution, today announced that Brendan Kennedy, President and Chief Executive Officer, and Mark Castaneda, Chief Financial Officer, Secretary and Treasurer, will present at the Barclays Global Consumer Staples Conference.
The presentation will be on Thursday, September 6, 2018 at 7:30 a.m. ET and the simultaneous, live webcast will be available on the Investors section of the Company’s website at www.tilray.com. The webcast will be archived for 30 days.
About Tilray®
Tilray is a global pioneer in cannabis research, cultivation, processing and distribution currently serving tens of thousands of patients in ten countries spanning five continents.
]]>
Canopy Rivers Provides Update on Upcoming Go Public Transaction]]>D.M.O. Newswirehttps://www.dailymarijuanaobserver.com/single-post/2018/08/23/CGC-WEED-Canopy-Rivers-Provides-Update-on-Upcoming-Go-Public-Transactionhttps://www.dailymarijuanaobserver.com/single-post/2018/08/23/CGC-WEED-Canopy-Rivers-Provides-Update-on-Upcoming-Go-Public-TransactionThu, 23 Aug 2018 15:38:10 +0000
Toronto, Aug. 23, 2018 — /D.M.O. Newswire/ — Canopy Rivers Corporation (“Canopy Rivers”), the venture capital investment platform of Canopy Growth Corporation (TSX:WEED) (NYSE:CGC) (“Canopy Growth”), is pleased to announce that it has set a date of September 12, 2018, for its upcoming shareholder meeting in connection with the proposed business combination involving AIM2 Ventures Inc. (“AIM2”) and Canopy Rivers (the “Go Public Transaction”).
As previously announced, Canopy Rivers has entered into a definitive amalgamation agreement with AIM2, which outlines the terms and conditions pursuant to which the parties will complete the Go Public Transaction. The Go Public Transaction will result in a reverse take-over of AIM2 by Canopy Rivers and will constitute AIM2’s “Qualifying Transaction” under Policy 2.4 – Capital Pool Companies of the TSXV Corporate Finance Manual.
Subject to receipt of all required approvals, including the final approval of the TSX Venture Exchange (the “TSXV”), the Go Public Transaction is expected to close and the subordinated voting shares of the resulting issuer are expected to commence trading on the TSXV under the symbol “RIV” during the week of September 17, 2018.
“With Canopy Rivers, we are well-positioned to take advantage of the universe of investment opportunities unfolding globally in the ever-expanding cannabis economy,” said Bruce Linton, Chairman and acting CEO of Canopy Rivers, and co-CEO of Canopy Growth. “The strategic relationship with Canopy Growth, strong management and access to capital will enable Canopy Rivers to build upon a proven track record and continue to develop a leading ecosystem of cannabis companies across the entire cannabis value chain.”
To date, Canopy Rivers has made investments in eleven domestic and international companies, establishing a diversified portfolio of licensed producers, late stage licensed producer applicants, pharmaceutical formulators, brand developers and distributors, retail networks, and technology and media platforms.
As previously announced, subject to the satisfaction of certain escrow release conditions, the net proceeds from Canopy Rivers’ $104 million subscription receipt financing are expected to be released from escrow in connection with the closing of the Go Public Transaction. The oversubscribed private placement, which was co-led by CIBC Capital Markets, GMP Securities L.P. and Eight Capital, on behalf of a syndicate of agents including Cormark Securities Inc., INFOR Financial Inc. and PI Financial Corp., closed on July 6, 2018.
About Canopy Rivers:
Canopy Rivers is a unique investment and operating platform structured to pursue investment opportunities in the emerging global cannabis sector. Canopy Rivers works collaboratively with Canopy Growth (TSX:WEED, NYSE: CGC) to identify strategic counterparties seeking financial and/or operating support. Canopy Rivers has developed an investment ecosystem of complementary cannabis operating companies that represent various segments of the value chain across the emerging cannabis sector. As the portfolio continues to develop, constituents will be provided with opportunities to work with Canopy Growth and collaborate among themselves, which Canopy Rivers believes will maximize value for its shareholders and foster an environment of innovation, synergy and value creation for the entire ecosystem.
Cautionary Note Regarding Forward-Looking Information
This press release contains statements which constitute “forward-looking information” within the meaning of applicable securities laws, including statements regarding the plans, intentions, beliefs and current expectations of Canopy Rivers with respect to future business activities and operating performance. Forward-looking information is often identified by the words “may”, “would”, “could”, “should”, “will”, “intend”, “plan”, “anticipate”, “believe”, “estimate”, “expect” or similar expressions and includes information regarding: the timing for the closing of the Go Public Transaction and the commencement of trading of the subordinated voting shares of the resulting issuer; the timing and anticipated release of the net proceeds from the subscription receipt financing; Canopy Rivers’ position and opportunity in the cannabis economy; the ability to build a leading ecosystem of cannabis companies; and the expected benefits to be obtained by Canopy Rivers’ portfolio companies. Investors are cautioned that forward-looking information is not based on historical facts but instead reflect Canopy Rivers’ management’s expectations, estimates or projections concerning future results or events based on the opinions, assumptions and estimates of management considered reasonable at the date the statements are made. Although Canopy Rivers believes that the expectations reflected in such forward-looking information are reasonable, such information involves risks and uncertainties, and undue reliance should not be placed on such information, as unknown or unpredictable factors could have material adverse effects on future results, performance or achievements of the combined company. Among the key factors that could cause actual results to differ materially from those projected in the forward-looking information are the following: the ability to consummate the Go Public Transaction; possible termination of the amalgamation agreement; the ability to obtain requisite regulatory and shareholder approvals and the satisfaction of other conditions to the consummation of the Go Public Transaction on the proposed terms and schedule; the potential impact of the announcement or consummation of the Go Public Transaction on relationships, including with regulatory bodies, employees, suppliers, customers and competitors; the re-rating potential following the consummation of the Go Public Transaction; changes in general economic, business and political conditions, including changes in the financial markets; changes in applicable laws, including the approval and implementation of the Cannabis Act; compliance with extensive government regulation; and the diversion of management time on the Go Public Transaction. This forward-looking information may be affected by risks and uncertainties in the business of Canopy Rivers and market conditions.
Should one or more of these risks or uncertainties materialize, or should assumptions underlying the forward-looking information prove incorrect, actual results may vary materially from those described herein as intended, planned, anticipated, believed, estimated or expected. Although Canopy Rivers has attempted to identify important risks, uncertainties and factors which could cause actual results to differ materially, there may be others that cause results not to be as anticipated, estimated or intended. Canopy Rivers does not intend, and does not assume any obligation, to update this forward-looking information except as otherwise required by applicable law.
]]>
5 of Today's Biggest Marijuana Stock Gainers - Wednesday, August 22nd]]>Steven Lachardhttps://www.dailymarijuanaobserver.com/single-post/2018/08/22/5-of-Todays-Biggest-Marijuana-Stock-Gainers---Wednesday-August-22ndhttps://www.dailymarijuanaobserver.com/single-post/2018/08/22/5-of-Todays-Biggest-Marijuana-Stock-Gainers---Wednesday-August-22ndWed, 22 Aug 2018 22:50:39 +0000
Out of over 200+ marijuana stocks, here are 5 of the biggest marijuana stock winners in trading on Wednesday, August 22nd including CV Sciences, Inc. (OTC:CVSI) and more...
CV Sciences, Inc. (OTC:CVSI)
rose 27.82% on higher than average trading volume on the OTC markets, closing the day at $7.13 USD per share. Today, CVSI announced that it has fully repaid the promissory note payable to Wiltshire, LLC.
Golden Leaf Holdings Ltd. (CSE:GLH) (OTC:GLDFF)
rose 9.05% on higher than average trading volume on the OTC markets, closing the day at $0.218 USD per share. Recently, Golden Leaf announced that it will report its financial results for the quarter ended June 30, 2018 on Wednesday, August 29, 2018, after market-close.
GW Pharmaceuticals Plc. (NASDAQ:GWPH)
rose 4.86%
on lower than average trading volume on the Nasdaq, closing the day at $144.17 USD per share. Recently, GW Pharmaceuticals announced financial results for the third quarter ended 30 June 2018.
Helix TCS, Inc. (OTC:HLIX)
Shares of Helix TCS, Inc.
rose 17.09% on higher than average trading volume on the OTC markets, closing the day at $1.37 USD per share. Recently, Helix TCS released its 8-K/A disclosing the pro-forma financial statements for the Company’s previously reported merger with Bio-Tech Medical Software, Inc.
Newstrike Brands Ltd. (TSXV:HIP) (OTC:NWKRF)
rose 12.73%
on higher than average trading volume on the OTC markets, closing the day at $0.5826 USD per share. Yesterday, Newstrike announced that its wholly-owned subsidiary, Up Cannabis Inc., has entered into an agreement naming it to the list of official suppliers to the Ontario Cannabis Store.
Tell us which marijuana stocks put you in the green today! Join the conversation in our Marijuana Stock Forum!
Conclusion
Find more about today's gainers by checking out their respective profiles in our global marijuana stock database via the linked tickers above. To stay up to date with important developments in the cannabis industry, be sure to subscribe to one or more of our free email newsletters. Also, connect with The Daily Marijuana Observer on Facebook, Twitter, StockTwits and
D/M/O
Disclaimer
Investing in nanocap, microcap, and small cap stocks is highly speculative. The publishers of DailyMarijuanaObserver.com are not registered as Investment Advisors or Broker-Dealers in any jurisdiction whatsoever. The information contained on DailyMarijuanaObserver.com (“this site”) has been prepared solely for informational purposes. Nothing on the site is an offer or solicitation to buy or sell securities. Investors should seek financial advice regarding the appropriateness of investing in any securities mentioned from their financial advisor.
]]>
5 of Today's Biggest Marijuana Stock Losers - Wednesday, August 22nd]]>Steven Lachardhttps://www.dailymarijuanaobserver.com/single-post/2018/08/22/5-of-Todays-Biggest-Marijuana-Stock-Losers---Wednesday-August-22ndhttps://www.dailymarijuanaobserver.com/single-post/2018/08/22/5-of-Todays-Biggest-Marijuana-Stock-Losers---Wednesday-August-22ndWed, 22 Aug 2018 22:25:18 +0000
Out of over 200+ marijuana stocks, here are just 5 of the biggest marijuana stock losers in trading on Wednesday, August 22nd including Isodiol International Inc. (CSE:ISOL) (OTC:ISOLF) and more...
Bang Holdings Corp. (OTC:BXNG)
dropped 27.31%
today on higher than average trading volume on the OTC markets, closing the day at $0.378 USD per share. Recently, Bang Holdings announced that the company has entered into an exclusive development agreement with The Arcview Group.
Indoor Harvest Corp. (OTC:INQD)
dropped 18.67%
on higher than average trading volume on the OTC markets, closing the day at $0.061 USD per share. Recently, Indoor Harvest announced first quarter results for 2018.
Isodiol International Inc. (CSE:ISOL) (OTC:ISOLF)
dropped 4.94%
on higher than average trading volume on the OTC markets, closing the day at $2.50 USD per share. Recently, Isodiol announced the progress of its months-long efforts to develop new hemp-based beers and functional beverages.
Marapharm Ventures Inc. (CSE:MDM) (OTC:MRPHF)
dropped 6.20% on higher than average trading volume on the OTC markets, closing the day at $3.46 USD per share. Recently, Marapharm updated shareholders on its proceedings to establish jurisdictional licensing in preparation for the sale of cannabis.
MassRoots, Inc. (OTC:MSRT)
Shares of MassRoots, Inc.dropped 7.41% on higher than average trading volume on the OTC markets, closing the day at $0.125USD per share. Recently, MassRoots provide an update on the roll-out of its dispensary portal, insight on recent and upcoming developments at the Company and key milestones for the fourth quarter of 2018.
Tell us which marijuana stocks burned you today! Join the conversation in our Marijuana Stock Forum!
Conclusion
Find more about today's losers by checking out their respective profiles in our global marijuana stock database via the linked tickers above. To stay up to date with important developments in the cannabis industry, be sure to subscribe to one or more of our free email newsletters. Also, connect with The Daily Marijuana Observer on Facebook, Twitter, StockTwits and Instagram!
D/M/O
Disclaimer
Investing in nanocap, microcap, and small cap stocks is highly speculative. The publishers of DailyMarijuanaObserver.com are not registered as Investment Advisors or Broker-Dealers in any jurisdiction whatsoever. The information contained on DailyMarijuanaObserver.com (“this site”) has been prepared solely for informational purposes. Nothing on the site is an offer or solicitation to buy or sell securities. Investors should seek financial advice regarding the appropriateness of investing in any securities mentioned from their financial advisor.
]]>
iAnthus to Release Q2 Financial and Operational Results on August 28]]>D.M.O. Newswirehttps://www.dailymarijuanaobserver.com/single-post/2018/08/22/IAN-iAnthus-to-Release-Q2-Financial-and-Operational-Results-on-August-28https://www.dailymarijuanaobserver.com/single-post/2018/08/22/IAN-iAnthus-to-Release-Q2-Financial-and-Operational-Results-on-August-28Wed, 22 Aug 2018 16:57:19 +0000
NEW YORK and TORONTO, Aug. 22, 2018 — /D.M.O. Newswire/ — iAnthus Capital Holdings, Inc. ("iAnthus" or the "Company"), (CSE:IAN) (OTC:ITHUF), which owns, operates, and partners with licensed cannabis operations throughout the United States, is pleased to announce that the company will release financial and operating results for the second quarter of 2018 ("Q2 2018") on August 28, 2018.
Following the release of the company's Q2 results, iAnthus executives will host a conference call and webcast to discuss the results and relevant company updates.
Additionally, iAnthus announced today that it has retained the services of Marcum LLP, a leading independent public accounting and advisory services firm in the United States, as its new corporate auditor, effective August 10, 2018.
The Notice of Change of Auditor, together with the required letters from Marcum, will be filed on SEDAR.
Conference Call and Webcast Details
The conference call for financial analysts and investors will take place at 8:45am ET on Wednesday, August 29, 2018. The call will be archived and available on iAnthus' website for replay. Please visit http://ir.ianthuscapital.com/ to access the archived conference call.
Dial-In Number: (888) 231-8191 or international: (647) 427-7450 Webcast: https://event.on24.com/wcc/r/1821966/5A289B907DC2DDA928EC0EADFDDFAC57
A replay of the call will be available for 7 days by dialing: (855) 859-2056
Additional information about iAnthus may be accessed on the Company's website at www.ianthuscapital.com and under the Company's SEDAR profile at www.sedar.com.
About iAnthus Capital Holdings, Inc.
iAnthus Capital Holdings, Inc. owns and operates best-in-class licensed cannabis cultivation, processing and dispensary facilities throughout the United States, providing investors diversified exposure to the U.S. regulated cannabis industry. Founded by entrepreneurs with decades of experience in operations, investment banking, corporate finance, law and health care services, iAnthus provides a unique combination of capital and hands-on operating and management expertise. The Company uses these skills to support operations across six states. For more information, visit www.iAnthusCapital.com.
SOURCE iAnthus Capital Holdings, Inc.
For further information: Corporate: Julius Kalcevich, Chief Financial Officer, iAnthus Capital Holdings, Inc., 646-518-9411, investors@ianthuscapital.com; US Investors: Phil Carlson / Elizabeth Barker, KCSA Strategic Communications, iAnthus@KCSA.com ; Canadian Investors: investors@ianthuscapital.com; Media: Robert Vanisko, North 6th Agency, 212-334-9753 ext.112, iAnthus@n6a.com
]]>
Namaste signs revenue-sharing agreement with Cannvas MedTech]]>D.M.O. Newswirehttps://www.dailymarijuanaobserver.com/single-post/2018/08/22/Namaste-signs-revenue-sharing-agreement-with-Cannvas-MedTechhttps://www.dailymarijuanaobserver.com/single-post/2018/08/22/Namaste-signs-revenue-sharing-agreement-with-Cannvas-MedTechWed, 22 Aug 2018 16:19:04 +0000
VANCOUVER, Aug. 22, 2018 — /D.M.O. Newswire/ — Namaste Technologies Inc. ("Namaste" or the "Company") (TSXV:N) (FRANKFURT:M5BQ) (OTC:NXTTF) is pleased to announce that it has signed a definitive revenue sharing agreement (the "Agreement") with Cannvas MedTech Inc. ("Cannvas") (CSE: MTEC, FRA: 3CM), a leading cannabis business technology company, whereby the two companies will share revenue generated through co-branding and marketing efforts between Namaste's medical cannabis patient portal, NamasteMD (or "NamasteMD.com") and the Cannvas.me cannabis education platform."
Under the terms of the Agreement, Cannvas and Namaste will build and deploy technologies driving customer acquisition and value-added services between company platforms. Both organizations will continue to explore other avenues to expand the partnership and enhance user experiences across their respective platforms.
Namaste is the world's largest and most comprehensive cannabis-focused e-commerce platform with 32 sites in 20 countries and over 600,000 monthly visits to their e-commerce sites with a database of approximately 1.5 million users. The Company's fully integrated e-commerce network spans across the globe offering everything from CBD products to rolling papers and vaporizers. In Canada, Namaste has developed the country's first cannabis telemedicine app, available on iPhone and Android devices, allowing patients to connect to doctors or nurse practitioners for consultations within 15 minutes from sign-up.
The Agreement represents a strategic initiative whereby Namaste is partnering with a technology platform to drive new patient acquisition and create value for its partners. With the use of NamasteMD, the Cannvas.me educational platform will offer users convenient access to book medical cannabis consultations through NamasteMD, providing added value for and a new revenue stream for Cannvas.me.
Steve Loutskou, COO of Cannvas MedTech Inc. comments: "As we close in on the launch of Cannvas.me, we are very excited to team up with Namaste Technologies. They have done an incredible job creating the world's largest and most comprehensive cannabis-focused e-commerce platform and make an ideal partner for Cannvas MedTech. We share a similar outlook of aspiring to partner with leading companies making a difference educating consumers about the benefits of medical cannabis. I look forward to working with the Namaste team and building a long-term and mutually beneficial partnership."
Kory Zelickson, Co-Founder and VP of Business Development for Namaste comments: "I am very impressed with the vision of Cannvas to become the unbiased source of education for medicinal and recreational cannabis users worldwide. With the legalization of cannabis in Canada only a few short months away, forming a long-term partnership with an educational platform furthers Namaste's commitment to its patients around the safe and responsible use of cannabis."
About Cannvas MedTech Inc.
Cannvas MedTech is a leading business technology company in the cannabis space. We design and build customer-centric solutions that enable our partners to harness the power of data to truly understand their customers, industry, and key business drivers.
About Namaste Technologies Inc.
Namaste Technologies is Your Everything Cannabis Store™. Namaste operates the largest global cannabis e-commerce platform with over 30 websites in 20+ countries under various brands. Namaste's product offering through its subsidiaries includes vaporizers, glassware, accessories, CBD products, and the company will soon be selling medical cannabis in the Canadian market, subject to approval by Health Canada.
Namaste has developed and acquired innovative technology platforms including NamasteMD.com, Canada's first Health Canada compliant telemedicine application, and in May 2018 the Company acquired a leading e-commerce AI and Machine Learning Company, Findify AB. Findify uses artificial intelligence algorithms to optimize and personalize a consumer's on-site buying experience. Namaste is focused on leveraging its cutting-edge technology to enhance the user experience throughout its platforms. Namaste will continue to develop and acquire innovative technologies which will provide value to the Company and to its shareholders as well as to the broader cannabis market.
On behalf of the Board of Directors
"Sean Dollinger"
Chief Executive Officer
Direct: +1 604-355-6100
Email: info@namastetechnologies.com
Further information on the Company and its products can be accessed through the links below:
NamasteTechnologies.com
NamasteMD.com
NamasteVapes.ca
Everyonedoesit.ca
FORWARD-LOOKING INFORMATIONThis press release contains forward-looking information based on current expectations. These statements should not be read as guarantees of future performance or results. Such statements involve known and unknown risks, uncertainties and other factors that may cause actual results, performance or achievements to be materially different from those implied by such statements. Although such statements are based on management's reasonable assumptions, Namaste assumes no responsibility to update or revise forward-looking information to reflect new events or circumstances unless required by law. Although the Company believes that the expectations and assumptions on which the forward-looking statements are based are reasonable, undue reliance should not be placed on the forward-looking statements because the Company can give no assurance that they will prove to be correct. Since forward-looking statements address future events and conditions, by their very nature they involve inherent risks and uncertainties. These statements speak only as of the date of this press release. Actual results could differ materially from those currently anticipated due to a number of factors and risks including various risk factors discussed in the Company's disclosure documents which can be found under the Company's profile on www.sedar.com. This press release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. The TSXV has neither reviewed nor approved the contents of this press release.
]]>
5 of Today's Biggest Marijuana Stock Gainers - Tuesday, August 21st]]>Steven Lachardhttps://www.dailymarijuanaobserver.com/single-post/2018/08/21/5-of-Todays-Biggest-Marijuana-Stock-Gainers---Tuesday-August-21sthttps://www.dailymarijuanaobserver.com/single-post/2018/08/21/5-of-Todays-Biggest-Marijuana-Stock-Gainers---Tuesday-August-21stTue, 21 Aug 2018 21:57:03 +0000
Out of over 200+ marijuana stocks, here are 5 of the biggest marijuana stock winners in trading on Tuesday, August 21st including CV Sciences, Inc. (OTC:CVSI) and more...
CV Sciences, Inc. (OTC:CVSI)
rose 32.50% on higher than average trading volume on the OTC markets, closing the day at $5.578 USD per share. Yesterday, it was announced that CV Sciences is being investigated by Block & Leviton LLP for violations of federal securities laws.
Golden Leaf Holdings Ltd. (CSE:GLH) (OTC:GLDFF)
rose 9.90% on higher than average trading volume on the OTC markets, closing the day at $0.1999 USD per share. Yesterday, Golden Leaf announced that it will report its financial results for the quarter ended June 30, 2018 on Wednesday, August 29, 2018, after market-close.
Helix TCS, Inc. (OTC:HLIX)
Shares of Helix TCS, Inc.
rose 8.33% on higher than average trading volume on the OTC markets, closing the day at $1.17 USD per share. Recently, Helix TCS released its 8-K/A disclosing the pro-forma financial statements for the Company’s previously reported merger with Bio-Tech Medical Software, Inc.
India Globalization Capital, Inc. (NYSE:IGC)
rose 20.20%
on higher than average trading volume on the NYSE, closing the day at $0.56 USD per share. Recently, India Globalization Capital announced that it has designated California as a priority market for Hyalolex.
Indoor Harvest Corp. (OTC:INQD)
rose 25.00%
on higher than average trading volume on the OTC markets, closing the day at $0.075 USD per share. Recently, Indoor Harvest announced first quarter results for 2018.
Tell us which marijuana stocks put you in the green today! Join the conversation in our Marijuana Stock Forum!
Conclusion
Find more about today's gainers by checking out their respective profiles in our global marijuana stock database via the linked tickers above. To stay up to date with important developments in the cannabis industry, be sure to subscribe to one or more of our free email newsletters. Also, connect with The Daily Marijuana Observer on Facebook, Twitter, StockTwits and
D/M/O
Disclaimer
Investing in nanocap, microcap, and small cap stocks is highly speculative. The publishers of DailyMarijuanaObserver.com are not registered as Investment Advisors or Broker-Dealers in any jurisdiction whatsoever. The information contained on DailyMarijuanaObserver.com (“this site”) has been prepared solely for informational purposes. Nothing on the site is an offer or solicitation to buy or sell securities. Investors should seek financial advice regarding the appropriateness of investing in any securities mentioned from their financial advisor.
]]>
5 of Today's Biggest Marijuana Stock Losers - Tuesday, August 21st]]>Steven Lachardhttps://www.dailymarijuanaobserver.com/single-post/2018/08/21/5-of-Todays-Biggest-Marijuana-Stock-Losers---Tuesday-August-21sthttps://www.dailymarijuanaobserver.com/single-post/2018/08/21/5-of-Todays-Biggest-Marijuana-Stock-Losers---Tuesday-August-21stTue, 21 Aug 2018 21:13:51 +0000
Out of over 200+ marijuana stocks, here are just 5 of the biggest marijuana stock losers in trading on Tuesday, August 21st including Blue Line Protection Group, Inc. (OTC:BLPG) and more...
Blue Line Protection Group, Inc. (OTC:BLPG)
dropped 5.51%
today on higher than average trading volume on the OTC markets, closing the day at $0.012 USD per share. Blue Line Protection Group provides armed protection, professional compliance and investigative services, and secure transportation services. The company has not released any news as of late.
CLS Holdings USA, Inc. (OTC:CLSH)
dropped 8.40%
on higher than average trading volume on the OTC markets, closing the day at $1.09 USD per share. Today, CLS Holdings announced that Matthew Janz has joined the Company as VP of Marketing and Director of Operations at Oasis Cannabis.
CROP Infrastructure Corp. (CSE:CROP) (OTC:CRXPF)
dropped 4.79%
on higher than average trading volume on the OTC markets, closing the day at $0.155 USD per share. Recently, CROP announced it had received confirmation that its San Bernardino dispensary application has passed stage one of the application review process.
MedMen Enterprises Inc. (CSE:MMEN) (OTC:MMNFF)
dropped 6.20% on higher than average trading volume on the OTC markets, closing the day at $3.46 USD per share. Yesterday, MedMen announced that based on tax revenue numbers reported recently by the State of California, MedMen stores accounted for roughly six percent of all legal retail sales of cannabis and cannabis products in the second quarter.
Phivida Holdings Inc. (CSE:VIDA) (OTC:PHVAF)
Shares of Phivida Holdings Inc.dropped 6.27% on higher than average trading volume on the OTC markets, closing the day at $0.5999 USD per share. Yesterday, Phivida announced that it has been awarded full DTC and CNS eligibility for its common shares that are listed for trading on the OTCQX Best Market.
Tell us which marijuana stocks burned you today! Join the conversation in our Marijuana Stock Forum!
Conclusion
Find more about today's losers by checking out their respective profiles in our global marijuana stock database via the linked tickers above. To stay up to date with important developments in the cannabis industry, be sure to subscribe to one or more of our free email newsletters. Also, connect with The Daily Marijuana Observer on Facebook, Twitter, StockTwits and Instagram!
D/M/O
Disclaimer
Investing in nanocap, microcap, and small cap stocks is highly speculative. The publishers of DailyMarijuanaObserver.com are not registered as Investment Advisors or Broker-Dealers in any jurisdiction whatsoever. The information contained on DailyMarijuanaObserver.com (“this site”) has been prepared solely for informational purposes. Nothing on the site is an offer or solicitation to buy or sell securities. Investors should seek financial advice regarding the appropriateness of investing in any securities mentioned from their financial advisor.
]]>
Future Farm's Florida Subsidiary Prepares for Cultivation with New Hire]]>D.M.O. Newswirehttps://www.dailymarijuanaobserver.com/single-post/2018/08/21/FFT-Future-Farms-Florida-Subsidiary-Prepares-for-Cultivation-with-New-Hirehttps://www.dailymarijuanaobserver.com/single-post/2018/08/21/FFT-Future-Farms-Florida-Subsidiary-Prepares-for-Cultivation-with-New-HireTue, 21 Aug 2018 16:05:49 +0000
Vancouver, British Columbia, Aug. 21, 2018 — /D.M.O. Newswire/ — via NEWMEDIAWIRE LLC -- Future Farm Technologies Inc. (the “Company” or “Future Farm”) (CSE:FFT) (OTC:FFRMF) announces that its Florida subsidiary, White Sand Nurseries (“WSN”) has hired Jose Sikaffy as Director of Cultivation in preparation for entering the Florida medical cannabis business. Mr. Sikaffy graduated from Valencia College in Orlando and holds a degree in plant science and agriculture technology. He was most recently employed as Cultivation Director of Remeny/Tredwell Nursery, a Florida licensed medical cannabis facility in Eustis.
“Mr. Sikaffy has a proven track record of successfully growing cannabis in Florida’s unique climate, and we are excited to have him on our team as we prepare our Florida cannabis application and facility plans,” said William Gildea, CEO of Future Farm. “His knowledge and use of the latest agriculture technology fits with Future Farm's vision, and we share a commitment to producing the highest quality medical cannabis for Florida patients.”
In January 2018, the Company acquired WSN to position itself in the fast-growing Florida cannabis market, which is expected to be the second largest market after California, with more than 100,000 registered medical cannabis patients and projected annual sales of US$1.6 billion in 2020, according to the Arcview Group. The WSN greenhouse fits the state’s stringent criteria and designated zoning to legally cultivate, process, and dispense cannabis.
The Company continues to operate the WSN greenhouse in full production while it applies for a cannabis cultivation license from the State of Florida. Pending license approval, the Company plans to upgrade the existing facility in preparation for cannabis production. The Company is also exploring the possibility of growing hemp on farmland acquired as part of the WSN transaction.
For further information, contact William Gildea, Director, at (888) 387-3761.
On behalf of the Board,
Future Farm Technologies Inc.
William Gildea, Chairman & CEO
About Future Farm Technologies Inc.
Future Farm is a Canadian company with holdings throughout North America including California, Massachusetts, Florida, Maine, Puerto Rico and Newfoundland. The Company’s mission is to advance sustainable agriculture through production of wholesale and retail cannabis products, including hemp. As a leader in its field, Future Farm is committed to using only the highest quality processes and products. Towards this goal, the Company acquires or partners with licensed cannabis operators, and acquires or develops leading technologies in cannabis production, breeding, genetics, and Controlled Environment Agriculture (CEA). Future Farm’s scalable, indoor CEA systems utilize minimal land, water and energy resources. The Company holds an exclusive, worldwide license to use a patented vertical farming technology that, when compared to traditional plant production methods, generates yields up to 10 times greater per square foot of land.
Neither the Canadian Securities Exchange nor its Market Regulator (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this release. The Canadian Securities Exchange has not in any way passed upon the merits of the proposed transaction and has neither approved nor disapproved the contents of this press release.
This news release may include forward-looking statements that are subject to risks and uncertainties. All statements within, other than statements of historical fact, are to be considered forward looking. Although the Company believes the expectations expressed in such forward-looking statements are based on reasonable assumptions, such statements are not guarantees of future performance and actual results or developments may differ materially from those in forward-looking statements. Factors that could cause actual results to differ materially from those in forward-looking statements include market prices, exploitation and exploration successes, continued availability of capital and financing, and general economic, market or business conditions. There can be no assurances that such statements will prove accurate and, therefore, readers are advised to rely on their own evaluation of such uncertainties. We do not assume any obligation to update any forward-looking statements except as required under the applicable laws.
]]>
FSD Pharma Completes Harvest and Microbial Testing of First Lot]]>D.M.O. Newswirehttps://www.dailymarijuanaobserver.com/single-post/2018/08/21/HUGE-FSD-Pharma-Completes-Harvest-and-Microbial-Testing-of-First-Lothttps://www.dailymarijuanaobserver.com/single-post/2018/08/21/HUGE-FSD-Pharma-Completes-Harvest-and-Microbial-Testing-of-First-LotTue, 21 Aug 2018 13:26:47 +0000
TORONTO, Aug. 21, 2018 — /D.M.O. Newswire/ — FSD Pharma Inc. ("FSD Pharma" or the "Company") (CSE:HUGE) (OTC:FSDDF) (FRA:0K9) is pleased to announce that its wholly-owned subsidiary, FV Pharma Inc. ("FV Pharma"), a licensed cannabis producer under the Access to Cannabis for Medical Purposes Regulations (the "ACMPR"), completed the harvest of its first lot of cannabis and successfully passed microbial testing required by Health Canada under the ACMPR and will be harvesting its second lot this week so as to conduct full analytical testing, thereby positioning FV Pharma to request a Pre-Sales License Inspection from Health Canada. The Pre-Sales License Inspection is the last step prior to the issuance of a Sales License under the ACMPR.
Thomas Fairfull, President and CEO of FSD Pharma stated, "This marks an important milestone for our Company as we expedite the growth of our business and the delivery of our business plan. We are extremely proud of our cultivation team that has delivered five high-quality strains and an impressive yield. Requesting our Pre-Sales License Inspection from Health Canada will position FV Pharma as one of the few independent companies with a cannabis sales license under the ACMPR in Canada. Once fully licensed, FV Pharma can begin selling cannabis for both the medicinal and recreational markets."
FSD Pharma operates its current cultivation facility in the former Kraft plant located in Cobourg, Ontario. The facility sits on a 70 acre parcel of land with 40 acres primed for development and an expansion capability of up to 3,896,000 square feet. The Company is currently in phase 1 of its growth plans with 25,000 square feet available to grow high-quality pharmaceutical grade cannabis flower. A further 220,000 square feet of growing capacity is under development with an anticipated completion date of December 2018. This expanded Phase 1 is expected to begin growing cannabis plants in January 2019 subject to approval by Health Canada.
"We are extremely pleased with the result of our first crop," said Zeeshan Saeed, EVP and Director of FSD Pharma. "We have delivered a highly efficient yield in our first harvest, which will be followed by a subsequent crop this week. We are well-positioned to complete our second harvest by the end of August 2018. We intend to continue to deliver the highest quality hydroponic indoor-grown pharmaceutical-grade cannabis from this point forward."
About FSD Pharma (CSE: HUGE) (OTC: FSDDF) (FRA: 0K9)
FSD Pharma through its wholly-owned subsidiary FV Pharma, is a licensed producer of marijuana under the Access to Cannabis for Medical Purposes Regulations (ACMPR) having received its cultivation license on October 13, 2017. Headquartered at the former Kraft plant in Cobourg, Ontario, approximately an hour's drive from Toronto, FV Pharma management's mission is to transform the facility into the largest hydroponic indoor cannabis facility in the world. FV Pharma intends to target all legal aspects of the cannabis industry, including cultivation, processing, manufacturing, extracts and research and development.
About FV Pharma
FV Pharma is a licensed producer under the Access to Cannabis for Medical Purposes Regulations (ACMPR), having received its cultivation license on October 13, 2017. Headquartered at the former Kraft plant in Cobourg, Ontario, approximately an hour's drive from Toronto, FV Pharma management's mission is to transform the facility into the largest hydroponic indoor cannabis facility in the world. FV Pharma intends to target all legal aspects of the cannabis industry, including cultivation, processing, manufacturing, extracts and research and development. For more information about FV Pharma, please visit www.fvpharma.com.
Forward-Looking Information
Certain statements contained in this press release constitute forward-looking information. These statements relate to future events or future performance. The use of any of the words "could", "intend", "expect", "believe", "will", "projected", "estimated" and similar expressions and statements relating to matters that are not historical facts are intended to identify forward-looking information and are based on the Corporation's current belief or assumptions as to the outcome and timing of such future events. Actual future results may differ materially. In particular, this release contains forward-looking information relating to the development of the Corporation's indoor cannabis facility and its business goals and objectives. The forward-looking information contained in this press release is made as of the date hereof, and the Corporation is not obligated to update or revise any forward-looking information, whether as a result of new information, future events or otherwise, except as required by applicable securities laws. Because of the risks, uncertainties and assumptions contained herein, investors should not place undue reliance on forward looking-information. The foregoing statements expressly qualify any forward-looking information contained herein.
Neither the Canadian Securities Exchange nor its regulation services provider accept responsibility for the adequacy or accuracy of this release.
]]>
Cronos Group Inc. Announces Provincial Supply Agreements]]>D.M.O. Newswirehttps://www.dailymarijuanaobserver.com/single-post/2018/08/21/CRON-Cronos-Group-Inc-Announces-Provincial-Supply-Agreementshttps://www.dailymarijuanaobserver.com/single-post/2018/08/21/CRON-Cronos-Group-Inc-Announces-Provincial-Supply-AgreementsTue, 21 Aug 2018 13:01:19 +0000
TORONTO, Aug. 21, 2018 — /D.M.O. Newswire/ — Cronos Group Inc. (NASDAQ:CRON) (TSX:CRON) ("Cronos Group" or the "Company"), a geographically diversified and vertically integrated cannabis group, is proud to announce its initial supply agreements for retail distribution, both government-operated and private, across Canada for the upcoming launch of the recreational market in October 2018.
Cronos Group has secured listings and signed binding master supply agreements with both the Ontario Cannabis Retail Corporation and the BC Liquor Distribution Branch. In combination, these provinces encompass over 50% of the Canadian population and hence the potential customer base which the Company is prepared to serve.
The Company has also secured listings and has accepted supplier terms with the Nova Scotia Liquor Corporation and Prince Edward Island Liquor Corporation. Cronos Group will be offering Dried Flower, Pre-Rolls and its highly rated Oils through both government-operated retail stores and online platforms across its three recreational brands.
Cronos Group plans to serve the Canadian recreational market through its bi-coastal production platform which includes facilities in British Columbia and Ontario. In combination, these facilities are expected to comprise 355,500 square feet of premium growing space. With access to over 1.2 million square feet of domestic capacity that is both actively licensed and committed facilities with production and sales licenses expected in the near future, Cronos Group is prepared to ensure premium quality product supply across the Canadian market.
"Cronos is excited to provide our premium quality products to Canadian consumers for the upcoming legalization and launch of the recreational market," said Mike Gorenstein, CEO of Cronos Group. "Day one we are ready to build and establish our brand through our premium products and we are committed to building strong relationships with the provinces and our customers."
About Cronos Group
Cronos Group is a globally diversified and vertically integrated cannabis company with a presence across four continents. The Company operates two wholly-owned Canadian licensed producers regulated under Health Canada's Access to Cannabis for Medical Purposes Regulations: Peace Naturals Project Inc., which was the first non-incumbent medical cannabis license granted by Health Canada, and Original BC Ltd., which is based in the Okanagan Valley, British Columbia. The Company has multiple international production and distribution platforms including in Germany, Poland, Israel and Australia. The Company intends to continue to rapidly expand its global footprint as it focuses on building an international iconic brand portfolio and develop disruptive intellectual property. Cronos Group is committed to building industry leading companies that transform the perception of cannabis and responsibly elevate the consumer experience.
Forward-looking statements
This news release contains "forward-looking information" and "forward-looking statements" within the meaning of applicable Canadian and U.S. securities laws. All information contained herein that is not clearly historical in nature may constitute forward-looking information. In some cases, forward-looking statements can be identified by words or phrases such as "may", "will", "expect", "plan", "anticipate", "intend", "potential", "estimate", "believe" or the negative of these terms, or other similar expressions intended to identify forward-looking statements. Some of the forward-looking statements contained in this press release, include the Company's ability to obtain locations and required licenses and permits to operate private retail stores in Canadian provinces, the development, construction of production facilities, anticipated size and capacity of the production facilities, the receipt of necessary funding, building permits and other approvals, including applicable production and sales licenses for the construction and operation of the production facilities, the Company's ability to supply the Canadian recreational market, its intention to continue to rapidly expand its global footprint, build an international iconic brand portfolio and develop disruptive intellectual property. Forward-looking statements are necessarily based upon a number of estimates and assumptions that, while considered reasonable by management, are inherently subject to significant business, economic and competitive risks, uncertainties and contingencies that may cause actual financial results, performance or achievements to be materially different from the estimated future results, performance or achievements expressed or implied by those forward-looking statements and the forward-looking statements are not guarantees of future performance. A discussion of some of the material risks applicable to the Company can be found in the Company's current MD&A and Annual Information Form, both of which have been filed on SEDAR and can be accessed at www.sedar.com. The forward-looking information included in this news release is made as of the date of this news release and, except as required by law, Cronos Group disclaims any obligation to update or revise any forward-looking statements. Readers are cautioned not to put undue reliance on these forward-looking statements.
]]>
5 of Today's Biggest Marijuana Stock Gainers - Monday, August 20th]]>Steven Lachardhttps://www.dailymarijuanaobserver.com/single-post/2018/08/20/5-of-Todays-Biggest-Marijuana-Stock-Gainers---Monday-August-20thhttps://www.dailymarijuanaobserver.com/single-post/2018/08/20/5-of-Todays-Biggest-Marijuana-Stock-Gainers---Monday-August-20thMon, 20 Aug 2018 22:11:30 +0000
Out of over 200+ marijuana stocks, here are 5 of the biggest marijuana stock winners in trading on Monday, August 20th including Aurora Cannabis Inc. (TSX:ACB) (OTC:ACBFF) and more...
Aurora Cannabis Inc. (TSX:ACB) (OTC:ACBFF)
rose 17.91% on higher than average trading volume on the OTC markets, closing the day at $5.86 USD per share. Today, Aurora announced it has set Friday August 24, 2018 as the record date for the distribution of Australis units.
Auxly Cannabis Group Inc. (TSXV:XLY) (OTC:CBWTF)
rose 13.20% on higher than average trading volume on the OTC markets, closing the day at $0.6679 USD per share. Recently, Auxly provided an update on the product strategy of the Company’s wholly owned subsidiary, Dosecann Inc.
General Cannabis Corp. (OTC:CANN)
rose 14.50%
on higher than average trading volume on the OTC markets, closing the day at $3.08 USD per share. Recently, General Cannabis announced financial results for the quarter ended June 30, 2018.
Golden Leaf Holdings Ltd. (CSE:GLH) (OTC:GLDFF)
rose 9.18% on higher than average trading volume on the OTC markets, closing the day at $0.1819 USD per share. Today, Golden Leaf announced that it will report its financial results for the quarter ended June 30, 2018 on Wednesday, August 29, 2018, after market-close.
Surna Inc. (OTC:SRNA)
Shares of Surna Inc.
rose 12.28%
on higher than average trading volume on the OTC markets, closing the day at $0.1435 USD per share. Recently, Surna announced operating and financial results for the three and six months ended June 30, 2018.
Tell us which marijuana stocks put you in the green today! Join the conversation in our Marijuana Stock Forum!
Conclusion
Find more about today's gainers by checking out their respective profiles in our global marijuana stock database via the linked tickers above. To stay up to date with important developments in the cannabis industry, be sure to subscribe to one or more of our free email newsletters. Also, connect with The Daily Marijuana Observer on Facebook, Twitter, StockTwits and
D/M/O
Disclaimer
Investing in nanocap, microcap, and small cap stocks is highly speculative. The publishers of DailyMarijuanaObserver.com are not registered as Investment Advisors or Broker-Dealers in any jurisdiction whatsoever. The information contained on DailyMarijuanaObserver.com (“this site”) has been prepared solely for informational purposes. Nothing on the site is an offer or solicitation to buy or sell securities. Investors should seek financial advice regarding the appropriateness of investing in any securities mentioned from their financial advisor.
]]>
5 of Today's Biggest Marijuana Stock Losers - Monday, August 20th]]>Steven Lachardhttps://www.dailymarijuanaobserver.com/single-post/2018/08/20/5-of-Todays-Biggest-Marijuana-Stock-Losers---Monday-August-20thhttps://www.dailymarijuanaobserver.com/single-post/2018/08/20/5-of-Todays-Biggest-Marijuana-Stock-Losers---Monday-August-20thMon, 20 Aug 2018 21:43:17 +0000
Out of over 200+ marijuana stocks, here are just 5 of the biggest marijuana stock losers in trading on Monday, August 20th including CV Sciences, Inc. (OTC:CVSI) and more...
CV Sciences, Inc. (OTC:CVSI)
dropped 36.31%
today on higher than average trading volume on the OTC markets, closing the day at $4.2099 USD per share. Today, it was announced that CV Sciences is being investigated by Block & Leviton LLP for violations of federal securities laws.
Diego Pellicer Worldwide, Inc. (OTC:DPWW)
dropped 12.20%
on higher than average trading volume on the OTC markets, closing the day at $0.0072 USD per share. Recently, Diego Pellicer announced that it has formed Diego Pellicer Management Company.
Global Hemp Group Inc. (CSE:GHG) (OTC:GBHPF)
dropped 9.29%
on higher than average trading volume on the OTC markets, closing the day at $0.0976 USD per share. Recently, Global Hemp Group provided an update on its Oregon hemp CBD farming project.
Players Network (OTC:PNTV)
Shares of Players Network
dropped 5.13% on higher than average trading volume on the OTC markets, closing the day at $0.037 USD per share. Recently, Players Network announced they have published a new Investor Presentation and will be publishing an accompanying video.
Solis Tek Inc. (OTC:SLTK)
Shares of Solis Tek Inc.dropped 5.19% on higher than average trading volume on the OTC markets, closing the day at $0.73 USD per share. Recently, Solis Tek provided a business update to its shareholders and the Wall Street community.
Tell us which marijuana stocks burned you today! Join the conversation in our Marijuana Stock Forum!
Conclusion
Find more about today's losers by checking out their respective profiles in our global marijuana stock database via the linked tickers above. To stay up to date with important developments in the cannabis industry, be sure to subscribe to one or more of our free email newsletters. Also, connect with The Daily Marijuana Observer on Facebook, Twitter, StockTwits and Instagram!
D/M/O
Disclaimer
Investing in nanocap, microcap, and small cap stocks is highly speculative. The publishers of DailyMarijuanaObserver.com are not registered as Investment Advisors or Broker-Dealers in any jurisdiction whatsoever. The information contained on DailyMarijuanaObserver.com (“this site”) has been prepared solely for informational purposes. Nothing on the site is an offer or solicitation to buy or sell securities. Investors should seek financial advice regarding the appropriateness of investing in any securities mentioned from their financial advisor.
]]>
Fire & Flower Announces Closing of C$27 Million Capital Raise]]>D.M.O. Newswirehttps://www.dailymarijuanaobserver.com/single-post/2018/08/20/Fire-Flower-Announces-Closing-of-C27-Million-Capital-Raisehttps://www.dailymarijuanaobserver.com/single-post/2018/08/20/Fire-Flower-Announces-Closing-of-C27-Million-Capital-RaiseMon, 20 Aug 2018 15:17:16 +0000
EDMONTON, Aug. 20, 2018 — /D.M.O. Newswire/ – Fire & Flower Inc. ("Fire & Flower"), an independent corporate cannabis retailer shared that it has successfully closed a convertible debenture capital raise resulting in aggregate gross proceeds of C$27,317,000 on August 1, 2018.
AltaCorp Capital Inc. and Richardson GMP Limited acted as co-lead agents for the offering. Significant participants in the capital raise included federally licensed producers Aphria Inc. and HEXO / The Hydropothecary Corporation, as previously announced.
Fire & Flower will use the funding for expansion and build-out of its stores in Alberta and Saskatchewan, working capital and general corporate purposes.
"With this capital raise and key strategic relationships in place, Fire & Flower is well-positioned to capture significant market share in Canadian retail cannabis markets," shared Trevor Fencott, Fire & Flower's Chief Executive Officer. "Fire & Flower is well capitalized as we execute our growth strategy in Canadian provinces allowing for private cannabis retail."
About Fire & Flower
Fire & Flower is a leading independent adult-use cannabis retailer poised to capture significant market share in Canadian provinces that allow private retail. The company will provide customers with expertly curated product selection and a best-in-class, education-driven customer experience.
Founded by leading legal cannabis entrepreneurs, Fire & Flower's leadership team carries extensive experience in launching successful businesses and within the legal cannabis industry. The company is versed in the national legalization of cannabis and is actively engaged in the evolution of the new cannabis industry across the country.
]]>
Liberty Leaf Completes CBD Study on K9 Pain Management]]>D.M.O. Newswirehttps://www.dailymarijuanaobserver.com/single-post/2018/08/20/LIB-Liberty-Leaf-Completes-CBD-Study-on-K9-Pain-Managementhttps://www.dailymarijuanaobserver.com/single-post/2018/08/20/LIB-Liberty-Leaf-Completes-CBD-Study-on-K9-Pain-ManagementMon, 20 Aug 2018 14:29:18 +0000
VANCOUVER, Aug. 20, 2018 — /D.M.O. Newswire/ – Liberty Leaf Holdings Ltd.(CSE:LIB) (OTC:LIBFF) (FSE:HN3P) ("Liberty Leaf" or the "Company) is pleased to announce the completion of its first CBD research trial on pain medication for dogs.
Liberty Leaf has a Collaborative Agreement with ESEV Research Development, a leading Israeli-American research and development company, for them to conduct research into the efficacy of CBD-containing products for treating specific medical conditions in pets. The project is being managed and overseen by Pharmaseed, ESEV's partner in Israel.
This is the first study of several to be conducted under the Collaborative Agreement. The study included large mixed-breed dogs, which received a proprietary CBD-infused oil formulation or placebo in the active phase of study. Oral CBD-infused oil provides the most effective means of delivery of CBD to dogs (Bartner et al. 2018. Can J. Vet. Res. 82:178-183).
The focus of this first study was on treating dogs with chronic osteoarthritic pain. Osteoarthritis (OA) is one of the most common diseases in dogs, characterized by pain, stiffness, lethargy and decreased mobility, which leads to reduction in their quality of life.
CBD offers a potential solution for both owner and pet. In fact, dogs should be able to take advantage of the pain management capabilities of CBD even more so than humans since dogs have a more extensive endocannabinoid system with which CBD can interact. This interaction helps to reduce pain and other symptoms linked to the endocannabinoid system.
Background
Reports of cannabis use in pets have to-date been primarily observational and uncontrolled. This anecdotal evidence seems to be enough for a growing number of pet owners to use CBD to treat their pets for various conditions, including chronic pain, anxiety, and epilepsy, as well as for a range of other afflictions.
According to a March 22, 2018 press release by the American Pet Products Association (APPA), Americans spent $69.51 billion on their pets in 2017, an amount that is projected to grow to $72.13 billion in 2018. Of this, veterinary care accounted for $17.07 billion in 2017, and is expected to reach $18.26 billion in 2018.
Until the use of CBD for management of pain in dogs with OA, common treatments included the use of nonsteroidal anti-inflammatory drugs (NSAIDs), which often have limited effectiveness and also adverse and undesirable side effects.
Study Results
Results from the ESEV-managed, randomized, placebo-controlled clinical trial demonstrated that dogs with clinically diagnosed OA receiving a daily dose of only 0.3 mg/kg of proprietary CBD-infused oil formulation for four weeks exhibited significantly reduced pain and improved functional performance. Daily CBD dosages for dogs have generally and arbitrarily been recommended in the range of 2-20 mg/kg.
"The ability to effectively manage pain with such a low CBD dosage as used in this study and over such a short treatment period is statistically significant," said Robert Jackman, Scientific Project Manager for Liberty Leaf.
According to Jackman, of the 16 dogs included in the study, only one did not benefit from the CBD treatment. The proprietary CBD-infused oil formulation used in the study was well tolerated, with no adverse or side effects reported by dog owners.
"This project was operated in multiple locations by a few different groups of researchers and project managers," noted Golan Vaknin, Executive Director for ESEV. He commented further. "The study was conducted productively and efficiently, and we are happy with the promising results showing positive effects of CBD for chronic pain in dogs."
The Opportunity
Future trials are being planned under Liberty Leaf's Collaborative Agreement with ESEV, including effective delivery options and dosing of CBD for treatment of pain in cats with OA. "We're excited about the progress of this initiative and the opportunities that it provides to Liberty Leaf in terms of being able to potentially license out our formula and/or to develop and market our own brand," said Will Rascan, President & CEO of Liberty Leaf.
About ESEV R&D
Based in New York, ESEV is collaborating with Israel's leading medical centers and scientific institutions to organize and oversee clinical trials to demonstrate the efficacy of cannabis-derived compounds and assist in the development of proprietary technologies for specific medical indications and overall wellbeing.
http://www.esevrd.com
About Pharmaseed Ltd.
Founded in 2003, Pharmaseed is Israel's largest GLP-certified pre-clinical CRO specializing in translational and regenerative studies. The company has all the necessities for NCE, biologics and medical-device development and first-in-man trials, such as safety evaluation in various animal models as well as complementary in-vitro/ex-vivo models and on-site human anatomy services.
Its competence lies in the pre-clinical projects, with large expertise in the following areas: Stem Cell and Cellular Therapeutics, Angiogenesis, Cancer, Inflammation, CNS, Pain, Metabolic Disorders, Toxicology and Medical Devices.
http://www.pharmaseedltd.com
About Liberty Leaf
Liberty Leaf Holdings Ltd. is a Canadian-based, public company whose focus is to build and support a diversified portfolio of cannabis-sector businesses, including cultivation, processing, value-added CBD/THC pet products and supply-chain products within this dynamic and fast-growing sector.
Liberty Leaf's late-stage ACMPR portfolio consists of a 60% interest in Just Kush and 100% of North Road Ventures. The company has launched its Signature Cannabis Retail division, an enterprise that is expected to roll out across Canada, bringing recreational cannabis to market for consumers.
On Behalf of the Board
Will Rascan, President & CEO Liberty Leaf Holdings Ltd. Phone: 778-819-0244 Toll Free: 1-833-LIB-LEAF (542-5323)
Twitter: @LibertyLeafCSE Facebook: LibertyLeafCSE
Neither the Canadian Securities Exchange nor its Market Regulator (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this release.
This news release may contain forward-looking statements based on assumptions and judgments of management regarding future events or results. Such statements are subject to a variety of risks and uncertainties, which could cause actual events or results to differ materially from those reflected in the forward-looking statements. The Company disclaims any intention or obligation to revise or update such statements.
]]>
MCIG Announces First Hemp Harvest With NYAcres to Begin Soon]]>D.M.O. Newswirehttps://www.dailymarijuanaobserver.com/single-post/2018/08/20/MCIG-Announces-First-Hemp-Harvest-With-NYAcres-to-Begin-Soonhttps://www.dailymarijuanaobserver.com/single-post/2018/08/20/MCIG-Announces-First-Hemp-Harvest-With-NYAcres-to-Begin-SoonMon, 20 Aug 2018 14:13:05 +0000
JACKSONVILLE, FL, Aug. 20, 2018 — /D.M.O. Newswire/ – mCig, Inc. (OTC:MCIG), a diversified company servicing the legal cannabis markets, announced today that it will begin harvesting its first crop of organic hemp from NYAcres in two to three weeks time.
To oversee the harvest and curing process, MCIG brought on Chadd McKeen , co-author of Idiots Guide: Growing Marijuana and founding partner at Canna Mana Trading Company. With over 12 years of experience in cannabis cultivation, Mr. McKeen will be onsite to jump-start the post-grow process, from the actual mechanics of the harvest to extraction and buyer relationships.
The NYAcres project began in June 2018 as a joint project with FarmOn!Foundation. The 55,000 pound yield of hemp bio-mass will be a huge growth generator for MCIG, its recently launched CBD Market (www.cbd.biz), and new CBD pet line, Artax (www.cbd.biz/portfolio/artax/).
After harvested and dried, cannabidiol (CBD) will be extracted from the plant source material. The particular strains of hemp grown at NYAcres, Cherry Wine and Berry Blue sourced from the Colorado Hemp Project are known for their high concentrations of CBD. Once extracted, CBD distillate can be used as a component for a diverse range of end user products, from CBD capsules to CBD vape. Initial projections from our Advisory team and based upon their collective years of farm production and development; we expect revenues greater than $10 million annually from the 40-acre yield. With 212 total acres available, the NYAcres Project could potentially yield up to $50 million per year in high demand CBD retail products with this unique approach.
“MCIG will continue to seek strategic partnerships in hemp agriculture,” says Paul Rosenberg, MCIG CEO. “The success of this venture with NYAcres is just the beginning. As the public demand for CBD and other hemp products grows, so does the need for a consistent hemp supply. With true hemp legalization on the horizon in the US, MCIG is well-positioned to capitalize on the growth of this soon-to-be billion dollar industry.”
About MCIG Group (MCIG)
Headquartered in Jacksonville, Florida, mCig, Inc. (MCIG) is a diversified company servicing the legal cannabis, hemp, and CBD markets via its lifestyle brands. mCig, Inc. is committed to being the leading distributor of technology, products, and services to fit the needs of a rapidly expanding industry.
Safe Harbor Statement:
Any statements contained in this press release that do not describe historical facts may constitute forward-looking statements as that term is defined in the Private Securities Litigation Reform Act of 1995. Any forward-looking statements contained herein are based on current expectations, but are subject to a number of risks and uncertainties. The factors that could cause actual future results to differ materially from current expectations include, but are not limited to, risks and uncertainties relating to the Company’s ability to develop, market and sell products based on its technology; the expected benefits and efficacy of the Company’s products and technology; the availability of substantial additional funding for the Company to continue its operations and to conduct research and development, and future product commercialization; and the Company’s business, research, product development, regulatory approval, marketing and distribution plans and strategies.
This release contains a non-GAAP disclosure, EBIDTA, which consists of net income plus interest expense, net, provision for income taxes and depreciation and amortization. This term, as the Company defines it, may not be comparable to a similarly titled measure used by other companies and is not a measure of performance presented in accordance with GAAP. The Company uses EBIDTA as a measure of operating performance. EBIDTA should not be considered as a substitute for net income.
]]>
Golden Leaf to Hold Conference Call to Review Second Quarter 2018]]>D.M.O. Newswirehttps://www.dailymarijuanaobserver.com/single-post/2018/08/20/GLH-Golden-Leaf-to-Hold-Conference-Call-to-Review-Second-Quarter-2018https://www.dailymarijuanaobserver.com/single-post/2018/08/20/GLH-Golden-Leaf-to-Hold-Conference-Call-to-Review-Second-Quarter-2018Mon, 20 Aug 2018 14:03:34 +0000
PORTLAND, Ore., Aug. 20, 2018 — /D.M.O. Newswire/ – Golden Leaf Holdings Ltd. ("GLH" or the "Company") (CSE:GLH) (OTC:GLDFF), a cannabis company with cultivation, production and retail operations built around recognized brands, today announced that it will report its financial results for the quarter ended June 30, 2018 on Wednesday, August 29, 2018, after market-close. Golden Leaf’s management, led by William Simpson, Chief Executive Officer, will also hold a conference call to review the results at 4:30 PM ET on Wednesday, August 29, 2018.
Mr. Simpson will be answering shareholder questions at the end of the call. Should you have questions prior to the conference call, please send an email to GLH@kcsa.com with ‘Golden Leaf Question’ in the subject line.
The dial-in information for the conference call is as follows:
Program Title: Golden Leaf Holdings Second Quarter 2018 Financial Results Call
Canada & U.S.: (877) 423-9813 International: (201) 689-8573 Participants must request the Golden Leaf Holdings Call.
A live audio webcast will be available online on Golden Leaf's website at goldenleafholdings.com, where it will be archived for one year.
An audio replay of the conference call will be available through midnight September 12, 2018 by dialing +1 (844) 512-2921 from the U.S. or Canada, or +1 (412) 317-6671 from international locations, Conference ID: 13682739.
To be added to the Golden Leaf email distribution list, please email GLH@kcsa.com with "GLH" in the subject line.
About Golden Leaf Holdings
Golden Leaf Holdings Ltd. is a Canadian company operating in multiple jurisdictions, including Oregon, Nevada and Canada, with cultivation, production and retail operations built around recognized brands. Golden Leaf distributes its products through its branded Chalice Farms retail dispensaries, as well as through third party dispensaries. Golden Leaf’s cannabis retail operations and products are designed with the customer in mind, focused on superlative in-store experience and quality products. Visit http://goldenleafholdings.com/ to learn more.
For further information, please contact:
Investor Relations:
Phil Carlson KCSA Strategic Communications pcarlson@kcsa.com 212-896-1233
Media Contacts: Anne Donohoe / Nick Opich KCSA Strategic Communications adonohoe@kcsa.com / nopich@kcsa.com 212-896-1265 / 212-896-1206
Company: William Simpson Chief Executive Officer Golden Leaf Holdings Ltd. 503-201-0659 William@chalicefarms.com
Disclaimer: This press release contains "forward-looking information" within the meaning of applicable securities legislation. Forward-looking information includes, but is not limited to, statements with respect to the Company’s future business operation, expectations of gross sales, the opinions or beliefs of management and future business goals, statements regarding the timing for opening of the Company’s sixth Chalice Farms dispensary. Generally, forward looking information can be identified by the use of forward-looking terminology such as "plans", "expects" or "does not expect", "is expected", "budget", "scheduled", "estimates", "forecasts", "intends", "anticipates" or "does not anticipate", or "believes", or variations of such words and phrases or state that certain actions, events or results "may", "could", "would", "might" or "will be taken", "occur" or "be achieved". Forward-looking information is subject to known and unknown risks, uncertainties and other factors that may cause the actual results, level of activity, performance or achievements of the Company to be materially different from those expressed or implied by such forward-looking information, including but not limited to general business, economic and competitive uncertainties, regulatory risks including risks related to the expected timing of the Company’s participation in the Adult Use market, market risks, risks inherent in manufacturing operations and other risks of the cannabis industry. Although the Company has attempted to identify important factors that could cause actual results to differ materially from those contained in forward-looking information, there may be other factors that cause results not to be as anticipated, estimated or intended. There can be no assurance that such information will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward looking information. Forward-looking information is provided herein for the purpose of presenting information about management’s current expectations relating to the future and readers are cautioned that such information may not be appropriate for other purpose. The Company does not undertake to update any forward-looking information, except in accordance with applicable securities laws. This Release does not constitute an offer of securities for sale in the United States, and such securities may not be offered or sold in the United States absent registration or an exemption from registration or an exemption from registration.
]]>
5 of Today's Biggest Marijuana Stock Gainers - Friday, August 17th]]>Steven Lachardhttps://www.dailymarijuanaobserver.com/single-post/2018/08/17/5-of-Todays-Biggest-Marijuana-Stock-Gainers---Friday-August-17thhttps://www.dailymarijuanaobserver.com/single-post/2018/08/17/5-of-Todays-Biggest-Marijuana-Stock-Gainers---Friday-August-17thFri, 17 Aug 2018 22:30:30 +0000
Out of over 200+ marijuana stocks, here are 5 of the biggest marijuana stock winners in trading on Friday, August 17th including CannTrust Holdings Inc. (TSX:TRST) (OTC:CNTTF) and more...
CannTrust Holdings Inc. (TSX:TRST) (OTC:CNTTF)
rose 6.78% on lower than average trading volume on the OTC markets, closing the day at $6.05199 USD per share. Recently, CannTrust announced financial and operating results for the three and six months ending June 30, 2018.
Canopy Growth Corporation (TSX:WEED) (NYSE:CGC)
rose 9.15% on higher than average trading volume on the OTC markets, closing the day at $33.75 USD per share. Recently, Canopy announced that Constellation Brands would invest $5 Billion CAD more into the company.
CV Sciences, Inc. (OTC:CVSI)
rose 17.83%
on higher than average trading volume on the OTC markets, closing the day at $6.61 USD per share. Recently, CV Sciences announced the appointment of Joseph Maroon, MD, FACS, to its Board of Directors.
Maricann Group Inc. (CSE:MARI) (OTC:MRRCF)
rose 9.09% on higher than average trading volume on the OTC markets, closing the day at $1.32 USD per share. Recently, Maricann announced that the company has successfully exported dry cannabis flowers to Germany.
Newstrike Brands Ltd. (TSXV:HIP) (OTC:NWKRF)
rose 4.94%
on higher than average trading volume on the OTC markets, closing the day at $0.4099 USD per share. Recently, Newstrike announced it had closed the transactions described in the investment agreement with Inner Spirit Holdings Ltd.
Tell us which marijuana stocks put you in the green today! Join the conversation in our Marijuana Stock Forum!
Conclusion
Find more about today's gainers by checking out their respective profiles in our global marijuana stock database via the linked tickers above. To stay up to date with important developments in the cannabis industry, be sure to subscribe to one or more of our free email newsletters. Also, connect with The Daily Marijuana Observer on Facebook, Twitter, StockTwits and
D/M/O
Disclaimer
Investing in nanocap, microcap, and small cap stocks is highly speculative. The publishers of DailyMarijuanaObserver.com are not registered as Investment Advisors or Broker-Dealers in any jurisdiction whatsoever. The information contained on DailyMarijuanaObserver.com (“this site”) has been prepared solely for informational purposes. Nothing on the site is an offer or solicitation to buy or sell securities. Investors should seek financial advice regarding the appropriateness of investing in any securities mentioned from their financial advisor.
]]>